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Abstract 
A successful pregnancy requires multiple adaptations in the mother’s brain that serve to 
optimise fetal growth and development, protect the fetus from adverse prenatal 
programming and prevent premature delivery of the young. Pregnancy hormones induce, 
organise and maintain many of these adaptations. Steroid hormones play a critical role and 
of particular importance is the progesterone metabolite and neurosteroid, 
allopregnanolone. Allopregnanolone is produced in increasing amounts during pregnancy 
both in the periphery and in the maternal and fetal brain. This review critically examines a 
role for allopregnanolone in both the maternal and fetal brain during pregnancy and 
development in protecting pregnancy and birth outcomes, with particular emphasis on its 
role in relation to stress exposure at this time. Late pregnancy is associated with suppressed 
stress responses. Thus, we begin by considering what is known about the central 
mechanisms in the maternal brain, induced by allopregnanolone, that protect the fetus(es) 
from exposure to harmful levels of maternal glucocorticoids as a result of stress during 
pregnancy. Next we discuss the central mechanisms that prevent premature secretion of 
oxytocin and consider a role for allopregnanolone in minimising the risk of preterm birth. 
Allopregnanolone also plays a key role in the fetal brain, where it promotes development 
and is neuroprotective. Hence we review the evidence about disruption to neurosteroid 
production in pregnancy, through prenatal stress or other insults, and the immediate and 
long-term adverse consequences for the offspring. Finally we address whether progesterone 
or allopregnanolone treatment can rescue some of these deficits in the offspring. 
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1. INTRODUCTION 
 
It is well established that sex steroids, such as estrogen and progesterone play critical roles 
in the brain both during development and throughout adult life.  They shape and organise 
the central nervous system (CNS) during development and have activating effects which 
influence brain function and a variety of behaviours.  
Progestogens are a group of steroid  hormones that include progesterone and are named as 
such due to their vital function in maintaining pregnancy ie. pro-gestational, though they 
also function in the non-pregnant animal. In females, they are synthesised primarily by the 
ovaries (corpus luteum), but can also be produced in the adrenals and liver and during 
pregnancy by the placenta and serve as precursors for the biosynthesis of other steroids, 
including estrogens, androgens, glucocorticoids and mineralocorticoids. Progestogens are 
also produced within the central nervous system where they are commonly referred to as 
neurosteroids.  
Progesterone is present in high levels during gestation and its actions in the uterus that 
serve to establish and maintain pregnancy, e.g. facilitating blastocyst implantation and 
maintaining uterine quiescence by reducing myometrial contractility, are well known 
(Graham and Clarke, 1997). Progesterone also acts in the brain during pregnancy and 
contributes to the preparation of the neural circuitry involved in the expression of maternal 
behaviour postpartum (Bridges, 1984; Numan, 2007). These roles for progesterone are well 
established; however important roles for central actions of the progesterone metabolite, 
allopregnanolone, during pregnancy in both the mother and in the neural development of 
the offspring are also becoming increasingly evident. 
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The concentration of allopregnanolone found in the brain is not static; it is dynamically 
altered under different physiological states, for example during development and pregnancy 
and in response to challenges such as stress (Maguire et al., 2009; Maguire and Mody, 2007; 
Paul and Purdy, 1992; Purdy et al., 1991). This review will examine the role of 
allopregnanolone in the maternal and fetal brain during pregnancy and development, with 
particular emphasis on its role in relation to stress exposure at this time. We will discuss 
what is currently known about the role of allopregnanolone in the brain in protecting 
pregnancy and birth outcomes, with a special focus on (i) the mechanisms in the maternal 
brain induced by allopregnanolone in late pregnancy that protect the fetus(es) from 
exposure to harmful levels of maternal glucocorticoids; (ii) the role of allopregnanolone 
actions on the central oxytocin system which minimise the risk of preterm birth; (iii) the 
neuroprotective effects of allopregnanolone formation in the fetal brain in response to 
insult; and (iv) the persistent adverse effects that inadequate allopregnanolone in the brain 
has on the offspring in later life.  
1.1. Neurosteroids and the brain 
The brain expresses the enzymes responsible for neurosteroidogenesis (Compagnone and 
Mellon, 2000; Furukawa et al., 1998) in neurones and glia (astrocytes and 
oligodendrocytes); hence the brain can produce neurosteroids de novo (Baulieu, 1991), or 
metabolise circulating steroid precursors produced in the periphery (which readily cross the 
blood-brain barrier) into neuroactive steroids. In the last few decades neurosteroids have 
generated much interest because of their ability to modulate neuronal excitability via rapid 
non-genomic actions and without mediation by classical steroid receptors (Paul and Purdy, 
1992). One of the most well studied neurosteroids is allopregnanolone (3α-hydroxy-5α-
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pregnan-20-one), a pregnane neurosteroid metabolite of progesterone. Allopregnanolone is 
generated by the sequential actions of 5α-reductase and 3α-hydroxysteroid dehydrogenase 
(3α-HSD). Progesterone is first converted into dihydroprogesterone (20α-hydroxy-4-
pregnen-3-one) by 5α-reductase (the rate-limiting enzyme), which is in turn converted into 
allopregnanolone by 3α-HSD (Penning et al., 1985; Russell and Wilson, 1994). The majority 
of allopregnanolone found in the brain is likely to be synthesised in the periphery (Mellon 
and Vaudry, 2001); however, allopregnanolone synthesising enzymes are expressed in the 
brain by astroglia, and 5-reductase activity is also found in neurones (Melcangi et al., 
1993). Moreover, allopregnanolone accumulates in the brain after removal of the adrenal 
glands and gonads (Baulieu, 1991; Cheney et al., 1995; Corpechot et al., 1993; Majewska, 
1992; Paul and Purdy, 1992; Purdy et al., 1991), indicating that allopregnanolone can be 
synthesised de novo in the brain. 
1.2. Allopregnanolone and potentiation of inhibitory GABA actions 
 
In contrast to its precursors, allopregnanolone does not bind to classical intracellular steroid 
receptors such as the progesterone receptor (PR), instead it exerts it actions via membrane 
bound GABAA receptors. The GABAA receptor is the predominant mediator of GABAergic 
neurotransmission in the central nervous system.  GABAA receptors are ligand-activated 
chloride channels comprised of five subunits (there are seven different subunit families, 
some with several variants) which form the chloride ion channel; the most common 
receptor stoichiometry is two α subunits, two β subunits and either a γ or δ subunit 
(Sieghart, 2006) (Fig. 1). When activated by GABA, the channel opens, permitting chloride 
ion influx and thus hyperpolarisation of the cell membrane (Fig. 1).  
10 
 
 
Allopregnanolone is a potent allosteric modulator at synaptic and extrasynaptic GABAA 
receptors, where it acts to positively modulate GABA action (Follesa et al., 2001). 
Allopregnanolone prolongs the opening time of chloride ion channels within GABAA 
receptors, thus enhancing inhibitory neurotransmission (Brussaard and Herbison, 2000; 
Lambert et al., 2009). The precise site(s) at which allopregnanolone acts on the GABAA 
receptor is unclear, though is distinct from the binding sites for GABA (Fig. 1), 
benzodiazepines, barbiturates and picrotoxin. The effectiveness of allopregnanolone action 
at the GABAA receptor to decrease neuronal excitability is dependent upon the subunit 
composition of the receptor (Belelli and Lambert, 2005), with allopregnanolone having 
greater efficacy at GABAA receptors containing the δ subunit than at those containing the γ2 
subunit (Adkins et al., 2001; Brown et al., 2002; Wohlfarth et al., 2002).  
 
GABAA receptors mediate two types of inhibitory neurotransmission: phasic inhibition which 
occurs at synapses and tonic inhibition which occurs at extrasynaptic sites (out with the 
synaptic cleft)(Belelli and Lambert, 2005). Phasic inhibition occurs when intermittently high 
levels of GABA released by exocytosis from presynaptic vesicles rapidly activate post-
synaptic GABAA receptors causing a transient inhibitory response. However, in addition, 
continuous low levels of ‘ambient’ GABA can act at extra-synaptic GABAA receptors giving 
rise to tonic inhibition. Allopregnanolone can modulate both synaptic and extrasynaptic 
GABAA receptors to potentiate both phasic and tonic inhibition and thus can exert 
significant influence over neuronal excitability (Belelli and Lambert, 2005; Brussaard et al., 
1997; Farrant and Nusser, 2005; Koksma et al., 2003).    
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1.3. Progesterone and allopregnanolone in the periphery and brain during pregnancy 
1.3.1. Essential role of progesterone 
 
Pregnancy is characterised by greatly elevated levels of circulating female sex steroids, in 
particular, estradiol and progesterone (Bridges, 1984) (Fig. 2a, b). These hormones ensure 
optimal conditions for maintenance of pregnancy and a successful pregnancy outcome, but 
also facilitate adaptations in the brain that prepare for timely parturition and lactation and 
permit the expression of appropriate maternal behaviour postpartum. Establishment and 
maintenance of pregnancy relies on the secretion of progesterone. In rats (also in mice and 
pigs), pregnancy is maintained by progesterone secreted by the corpora lutea, whereas in 
other species (e.g. sheep, women) the placenta takes over the production of progesterone.  
 
Progesterone concentrations in human pregnancy far exceed those required to saturate 
uterine receptors, hence maintaining uterine quiescence and cervical integrity and 
preventing abortion or labour (Challis, 2000). This may be because progesterone 
metabolism is required to maintain gestational neuroactive steroid concentrations in the 
maternal and fetal circulation as well as other functions, such as regulating maternal 
immune tolerance during gestation (Piccinni et al., 1995).  
1.3.2. Allopregnanolone 
 
Increased levels of progesterone in the maternal circulation are accompanied by increased 
levels of allopregnanolone both in the blood (Fig. 3a) and in the brain (Fig. 3b) (Concas et al., 
1998). In rats, circulating and central progesterone levels peak at approximately 10-fold 
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greater levels on gestational day 15, than those observed pre-pregnancy; whereas 
allopregnanolone in the maternal brain does not reach maximal levels until day 19-20, near 
the end of pregnancy (Concas et al., 1998). In pregnant women, plasma allopregnanolone 
levels are elevated during gestation in both the maternal and fetal circulation (Bicikova et 
al., 2002). Moreover, studies in sheep have demonstrated that during late gestation 
allopregnanolone concentrations in the fetal brain are also increased reaching maximal 
levels near term, before falling dramatically after birth (Nguyen et al., 2003).  
 
The fetal brain is exposed to substantial levels of progesterone, as well as its neuroactive 
metabolites e.g. allopregnanolone.  This progesterone has been shown to also contribute to 
the cell proliferation and overall growth of the brain (Schumacher et al., 2000) (Schumacher 
et al., 2012); however, the contribution of neuroactive steroid synthesis pathways may 
differ between species. In the sheep, metabolism of progesterone produced by the placenta 
leads to lower progesterone and higher metabolite levels in the fetal circulation (Crossley et 
al., 1997). In contrast, human maternal progesterone concentrations are markedly higher 
than in the sheep and, despite metabolism, progesterone concentrations have been 
reported to be higher again in the fetal circulation (Hill et al., 2010). The concentrations of 
several neuroactive metabolites are also higher in the fetal circulation compared to 
maternal levels (Hill et al., 2010; Lofgren and Backstrom, 1997). The human placenta 
produces a number of metabolites that may be neuroactive as well as allopregnanolone, 
however little is known regarding the concentration of these metabolites in the fetal brain.   
1.3.3. Neurosteroidogenic enzymes 
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Regulation of neuroactive steroid concentrations in the fetal and maternal brain is complex 
and involves intimate interactions between the placenta and the brain itself (Fig. 4). As 
mentioned above, the enzymes required for the production of progesterone and its 
metabolism to allopregnanolone are present in the brain (Melcangi et al., 2008). The 
capacity of the maternal brain to generate neurosteroids is increased in pregnancy (Brunton 
et al., 2009). In late pregnant rats, 5α-reductase activity is increased in the maternal 
hypothalamus and mRNA expression is up-regulated in the nucleus tractus solitarii (NTS) of 
the brainstem (Brunton et al., 2009). 3α-HSD mRNA expression is also increased in the 
paraventricular nucleus (PVN) in late pregnancy (Brunton et al., 2009). Together this up-
regulated expression of genes for the synthesising enzymes is expected to lead to increased 
allopregnanolone generation for local action on neurones (see Sections 2.2, 3.6.-3.8.). 
Moreover, we have also shown expression of 5α-reductase isoforms are localized in fetal 
sheep and guinea pig brains throughout late pregnancy (Kelleher, 2013; Nguyen et al., 
2003). During fetal life concentrations of neuroactive steroids in the brain are augmented by 
both the production of neuroactive steroids as well as precursor supplementation from the 
placenta (Fig. 4).   
 
5α-Reductase enzyme activity may be the major determinant of the levels of neuroactive 
steroids found locally within regions of the brain. Total activity may be a product of the 
activities of the two 5α-reductase isoforms, type-1 and type–2.  Both isoforms are expressed 
in fetal sheep and guinea pig brains throughout late gestation.  Evidence suggests however, 
that 5α-reductase-2 expression contributes most to the production of allopregnanolone in 
the fetal and neonatal brain (Martini, 1982; Nguyen et al., 2003). Furthermore, double-
labelling studies have shown that 5α-reductase-2 is strongly expressed in glial cells and 
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neurones in the hippocampus and cerebellum and may control allopregnanolone levels at 
specific sites (Petratos et al., 2000). Expression is also seen in oligodendrocytes in the sub-
cortical white matter of the fetal sheep brain (Petratos et al., 2000). This is consistent with 
the higher levels of allopregnanolone found in white matter regions in late gestation and 
with a role for allopregnanolone in myelination (Mellon, 2007; Nguyen et al., 2003)  
 
In human studies, we have reported that both 5α-reductase isoforms are expressed in the 
placenta (Vu et al., 2009). This results in the formation of 5α-dihydroprogesterone, the 
immediate precursor of allopregnanolone (Milewich et al., 1979). The level of expression of 
these isoforms is markedly lower in placentae from preterm deliveries (<37 completed 
weeks) compared to those collected at term (Vu et al., 2009). These observations suggest 
the placenta contributes directly and indirectly to the allopregnanolone found in the 
circulation and potentially the fetal brain. Together these observations indicate that 
increasing expression of 5α-reductase-2 in placenta and brain work together to maintain 
and increase allopregnanolone concentrations in pregnancy. Hence placental insufficiency 
or other pathologies may influence allopregnanolone levels in the brain.  
 
The mechanism by which neurosteroidogenic enzyme expression in the brain is regulated in 
pregnancy is unclear. Ovarian hormones have been shown to regulate 3α-HSD activity in the 
hypothalamus (Bertics et al., 1987), and 17β-estradiol, but not progesterone, increases 
hippocampal 3α-HSD mRNA expression (Mitev et al., 2003). To date, there is no evidence to 
indicate that either estrogen or progesterone regulates 5α-reductase expression in the brain 
in pregnancy, however one study has shown that increased levels of prolactin may be 
involved (Sanchez et al., 2008).  
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2. ALLOPREGNANOLONE AND MATERNAL NEUROENDOCRINE STRESS RESPONSES IN 
PREGNANCY  
 
2.1 The hypothalamo-pituitary-adrenal axis 
 
Stress exposure rapidly increases allopregnanolone levels in the brain (Barbaccia, 1997; 
Purdy et al., 1991; Vallée, 2000) and allopregnanolone can modulate neuroendocrine 
responses to stress (Patchev et al., 1996; Patchev et al., 1994). The hypothalamo-pituitary-
adrenal (HPA) axis is the key neuroendocrine system that responds to and regulates stress 
responses, which serve to restore physiological homeostasis following stressful stimuli. At 
the apex of the system in the hypothalamus are a population of hypophysiotropic neurones 
located in the medial parvocellular subdivision of the paraventricular nucleus (pPVN) which 
synthesise the ACTH secretagogues, corticotropin releasing hormone (CRH) and/or arginine 
vasopressin (AVP) (Fig. 5). Both physical and psychological stressors activate the HPA axis, 
thus when activated these neurones secrete CRH and/or AVP from their nerve terminals at 
the median eminence into the hypothalamo-hypophysial portal blood.  CRH and AVP act 
synergistically via CRH-R1 and V1b receptors, respectively, on anterior pituitary 
corticotropes to stimulate the release of ACTH into the general circulation. ACTH in turn acts 
via melanocortin-2 (MC-2) receptors to trigger glucocorticoid (corticosterone or cortisol, 
depending on species) synthesis and secretion from the adrenal cortex. Glucocorticoids 
have diverse actions in facilitating appropriate responses to stress. They promote metabolic 
adaptations (Munck and Koritz, 1962), facilitate cardiovascular responses (Zhu et al., 1995) 
and modulate immune (Besedovsky and Del Rey, 1992) and behavioural responses. 
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Critically, glucocorticoids also act via glucocorticoid (GR) and mineralocorticoid receptors 
(MR) to exert negative feedback control of the HPA axis and terminate the stress response 
when the stress no longer poses a threat (Dallman et al., 1992). 
2.1.1. Stress circuitry and the HPA axis 
 
The PVN receives diverse afferent inputs by which stressful stimuli may influence HPA axis 
activity (Swanson and Sawchenko, 1980; Ziegler and Herman, 2002). Stressors are typically 
categorised as either physical or psychological and the brain circuitry activated is dependent 
upon the type of stress the animal is exposed to (Sawchenko et al., 2000). Psychological 
stressors (e.g. open field in rodents, public speaking in humans) involve sensory processing 
and have a distinct cognitive component and as such are typically processed and integrated 
by multisynaptic rostral cortico-limbic brain regions such as the medial prefrontal cortex, 
bed nucleus of the stria terminalis (BnST), hippocampus, amygdala and septum, which 
regulate the activity of the pPVN CRH neurones (Herman and Cullinan, 1997; Sawchenko et 
al., 1996). These rostral inputs to the PVN are primarily glutamatergic or GABAergic 
(Herman et al., 2002). In contrast, physical stressors (eg. infection) usually signify a real 
threat to survival, hence it is advantageous to bypass cognitive processing and rapidly 
convey information to the PVN; these stressors are processed primarily through caudal 
brainstem regions (Herman et al., 2003). For example, the nucleus of the solitary tract (NTS) 
in the brainstem is the principal recipient of sensory information carried by the vagus and 
provides excitatory noradrenergic input (direct and indirect) to the CRH neurones in the PVN 
in response to various physical stressors, including infection (Ericsson et al., 1994; Herman 
and Cullinan, 1997; Li et al., 1996). While the rostral and caudal stress processing networks 
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are quite distinct there is cross-talk between them, mediated via reciprocal neural 
connections which permit functional integration of stress responses (Buller et al., 2003; 
Dayas et al., 2004; Herman et al., 2003).  
 
2.2. Maternal HPA axis stress responses in late pregnancy 
 
Maternal stress or glucocorticoid exposure during pregnancy can ‘program’ the 
development of physiological systems in the fetus(es), resulting in increased susceptibility to 
various pathologies in later life (see Section 4.5). However, there are two inherent 
mechanisms that seemingly protect the fetus from adverse programming by stress during 
pregnancy. Firstly, maternal HPA axis responses to stress are markedly suppressed in late 
pregnancy (Brunton et al., 2008b)(this Section). It is considered that this mechanism 
minimises fetal exposure to excessive levels of glucocorticoids in utero, and hence 
detrimental fetal programming, but also promotes appropriate metabolic adaptations 
necessary for a successful pregnancy outcome (Herrera, 2000). Secondly, as a last maternal 
line of defence, the placenta expresses the barrier enzyme, 11-hydroxysteroid 
dehydrogenase type 2 (Welberg et al., 2000), which catalyses the conversion of active 
corticosterone or cortisol into inactive cortisone and thus also limits fetal exposure to 
circulating maternal glucocorticoids.    
 
In rodents, late pregnancy (i.e. the last week of gestation) is associated with maternal HPA 
axis responses to acute stress that are progressively and substantially attenuated compared 
with early pregnancy or non-pregnant animals (da Costa et al., 1996; Douglas et al., 2003; 
Neumann et al., 1998). This is indicated by reduced ACTH and corticosterone secretion into 
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blood, concomitant with reduced activation of the hypophysiotropic parvocellular CRH/AVP 
neurones in the PVN following stress exposure (da Costa et al., 1996), and is found for both 
physical (e.g. immune challenge with the cytokine, interleukin-1β; IL-1β)(Brunton et al., 
2005) and psychological stressors (e.g. novel environment)(Douglas et al., 2003; Neumann 
et al., 1998), including those considered to have particular ethological relevance to rodents 
(e.g. social stress)(Brunton and Russell, 2010b). 
 
Although the majority of evidence has come from rodents (Brunton et al., 2008b), the 
phenomenon of reduced HPA axis stress responses in pregnancy is not unique to these 
species. Clinical studies have amply demonstrated that the HPA axis is also less sensitive to 
stress in pregnant women (Hartikainen-Sorri et al., 1991; Kammerer et al., 2002; Schulte et 
al., 1990).   
 
2.2.1. Role of allopregnanolone in HPA axis hyporesponsiveness in pregnancy  
 
While adaptations at the anterior pituitary contribute to reduced HPA axis responses to 
stress in late pregnancy in the rat (Ma et al., 2005b; Neumann et al., 1998), altered central 
control of the HPA axis is predominately responsible (Brunton et al., 2009; Brunton et al., 
2005). Stress exposure during late pregnancy is associated with a substantial reduction in 
activation of the pPVN neurones and reduced stimulation of CRH and/or AVP mRNA 
expression in the pPVN, which indicate reduced central drive of the HPA axis in late 
pregnancy.  
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This altered responsiveness of the HPA axis to stress in pregnancy is induced by the actions 
of allopregnanolone on the brain. Thus blocking allopregnanolone production in pregnant 
rats with overnight administration of either finasteride (a 5α-reductase inhibitor, which has 
been shown to reduce brain allopregnanolone content by up to 90%) (Concas et al., 1998) or 
4-MA (17β-(N,N-diethyl)carbamoyl-4-methyl-4-aza-5α-androstan-3-one)(Geldof et al., 1992) 
substantially restores HPA axis responses to physical and emotional stressors (Brunton et 
al., 2009)(Ma S and Russell JA, unpubl.). Moreover, in males and non-pregnant females, 
peripheral allopregnanolone administration suppresses HPA axis responses to stress 
(Brunton et al., 2009; Patchev et al., 1996). However, mimicking the sex steroid milieu of 
pregnancy in virgin females with treatment regimens of 17β-estradiol alone or combined 
with progesterone (with and without progesterone withdrawal) (Douglas et al., 2000), 
progesterone only (Brunton et al., 2009) or dihydroprogesterone (DHP) alone (Brunton et 
al., 2009) all fail to suppress HPA axis responses to stress. The ineffectiveness of the 
allopregnanolone precursors, progesterone and DHP, even in the presence of pregnancy 
levels of estrogen, to attenuate HPA axis responses to stress highlights the important role 
allopregnanolone plays and furthermore indicates that up-regulation of the 
allopregnanolone synthesising enzymes in the brain in late pregnancy (Brunton et al., 2009) 
(See Section 1.3.3.) is a critical prerequisite. 
  
2.2.2. Allopregnanolone and induction of endogenous opioid inhibitory mechanisms  
 
Endogenous opioid peptides play a modulatory role in HPA axis regulation. In males and 
non-pregnant females opioids (e.g. morphine), potentiate, while naloxone (an opioid 
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receptor antagonist) attenuates HPA axis responses to stress (Buckingham and Cooper, 
1986). Moreover, naloxone administration reduces IL-1-evoked Fos induction in CRH 
neurones in the pPVN (Buller et al., 2005), indicating a central action in the non-pregnant 
animal.  
 
However, in late pregnancy the direction of opioid action switches to a net inhibitory effect 
on HPA axis activity, and a central endogenous inhibitory opioid mechanism that functions 
to restrain HPA axis responses to stress emerges (Brunton et al., 2005; Douglas et al., 
1998a). Thus, in contrast to non-pregnant rats, ACTH and corticosterone secretory 
responses to stressors/stimuli that would normally activate the HPA axis are suppressed in 
late pregnancy. Endogenous opioid inhibition over these responses in late pregnant rats is 
revealed by systemic administration of naloxone, which reinstates HPA axis responses to 
stressors such as forced swimming, immune challenge, gastrointestinal peptides, orexigenic 
peptides (Bales, 2005; Brunton et al., 2005; Douglas et al., 2005; Douglas et al., 1998a), and 
to parturition-related stimuli (Wigger et al., 1999).  
 
These inhibitory actions of opioids are also exerted centrally in pregnancy. Systemic 
naloxone administration prior to IL-1β challenge results in increased activation of the 
neurones in the pPVN, as indicated by Fos expression (the protein product of the immediate 
early gene, c-fos; commonly used as an indicator of recent neuronal activation)(Brunton et 
al., 2012) and increased CRH mRNA expression in the pPVN to similar levels as observed in 
non-pregnant rats (Brunton et al., 2005). The site of action of the endogenous opioid(s) is 
evidently on excitatory terminals in the PVN, at least in the case of physical stressors that 
signal to the CRH neurones in the pPVN via the brainstem (Brunton et al., 2005).  This 
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brainstem excitatory input is from noradrenergic A2 neurones located in the NTS, which 
send projections directly (and indirectly via the parabrachial nucleus or central nucleus of 
the amygdala [CeA] and bed nucleus of the stria terminalis) to the medial pPVN (Buller et al., 
2004; Ericsson et al., 1994)(Fig. 5). Physical stressors, such as forced swimming, systemic 
cholecystokinin (CCK) and IL-1, activate these neurones hence stimulating noradrenaline 
release from their nerve terminals onto the CRH neurones in the pPVN (Douglas et al., 2005; 
MohanKumar and Quadri, 1993; Plotsky, 1987; Terrazzino et al., 1995; Ueta et al., 1993), 
which express 1 adrenergic receptors (Day et al., 1999). In late pregnancy and in contrast 
to virgin rats, these stressful stimuli fail to evoke noradrenaline release in the PVN (Brunton 
et al., 2005; Douglas et al., 2005)(despite retained activation of the A2 cell bodies in the NTS 
in pregnancy)(Brunton et al., 2005), hence HPA axis responses are absent or markedly 
reduced. Naloxone retro-dialysed directly into the PVN, reinstates IL-1β-evoked 
noradrenaline release in the PVN in late pregnant rats (Brunton et al., 2005), indicating that 
in late pregnancy endogenous opioids act presynaptically on noradrenergic nerve terminals 
in the pPVN to inhibit noradrenaline release thereby reducing excitatory input to the CRH 
neurones (Fig. 5). A similar mechanism has been demonstrated previously for CCK-induced 
noradrenaline release in the supraoptic nucleus (Onaka et al., 1995b) (see Section 3.8.3).  
 
NTS neurones synthesise enkephalins and dynorphins (Bronstein et al., 1992; Ceccatelli et 
al., 1992) and in late pregnancy, proenkephalin-A (pENK-A) mRNA and μ-opioid receptor 
mRNA expression is up-regulated in the NTS (Brunton et al., 2005). Thus the NTS is a likely 
source of the endogenous opioid that, following axonal transport to the terminals in the 
PVN, is involved in pre-synaptically inhibiting noradrenaline release. It is proposed that in 
late pregnancy activation of the NTS neurones by IL-1 triggers the release of enkephalin 
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from their terminals in the PVN, which acts pre-synaptically on up-regulated -opioid 
receptors and inhibit noradrenaline release to provide a mechanism through which 
excitatory noradrenergic drive from the brainstem to the CRH neurones in the PVN can be 
selectively auto-inhibited, thereby suppressing HPA axis responses to stress (Fig. 5). 
 
The inhibitory opioid mechanism described above that emerges in pregnancy is induced and 
maintained by allopregnanolone. In non-pregnant rats, allopregnanolone treatment to 
mimic pregnancy, induces inhibitory opioid tone over ACTH responses to stress (Brunton et 
al., 2009) and up-regulates pENK-A mRNA expression in the NTS by approximately 35% 
(Brunton et al., 2009), equivalent to the increase observed at the end of pregnancy (Brunton 
et al., 2005). Furthermore, the elevated levels of pENK-A mRNA in the NTS in late pregnancy 
are reduced to non-pregnant levels within 24h of blocking allopregnanolone synthesis with 
finasteride (Brunton et al., 2009). The mechanism by which allopregnanolone up-regulates 
opioid gene expression in the NTS in pregnancy is not known. It may involve an interaction 
with the GABAA receptors as has been reported for CRH and vasopressin gene expression in 
parvocellular neurones in the PVN (Bali and Kovacs, 2003) and for oxytocin gene expression 
in the magnocellular PVN neurones at the end of pregnancy (Blyth et al., 2000) (See Section 
3.7.). 
 
In contrast to the rat, enhanced endogenous opioid inhibition does not appear to underlie 
reduced HPA axis responses to stress during late pregnancy in mice (Douglas et al., 2003); 
however it is not clear whether allopregnanolone plays a role in reducing HPA axis 
responses in pregnant mice.  
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2.2.3. Allopregnanolone and GABAA receptor interactions in pregnancy 
 
It is not yet known whether allopregnanolone has a direct local effect on the GABA inputs to 
the CRH neurones in late pregnancy, as shown for oxytocin neurones (see Section 3.7). CRH 
neurones in the pPVN are under direct inhibitory GABAergic control (Miklos and Kovacs, 
2002), and allopregnanolone has been shown to enhance GABAA receptor-mediated 
synaptic inhibition of presumptive CRH neurones in the medial pPVN in hypothalamic slices 
from mice (Gunn, 2010). Therefore, one may predict that the increased levels of 
allopregnanolone in the maternal brain in pregnancy may enhance the action of GABA in the 
PVN or on afferent inputs to the CRH neurones, thus suppressing HPA axis stress responses; 
however, this remains to be tested. 
As mentioned above (Section 1.2.), allopregnanolone is more efficacious at GABAA receptors 
containing the δ subunit than at those containing the γ2 subunit (Adkins et al., 2001; Brown 
et al., 2002; Wohlfarth et al., 2002). Elevated levels of allopregnanolone in the maternal 
brain in late pregnancy are associated with altered expression of GABAA receptor isoforms in 
the hippocampus (Sanna et al., 2009): there is an increase in the expression of GABAA 
receptors containing a δ subunit and a decrease in γ2 subunit-containing GABAA receptor 
expression. Given the role of the hippocampus in HPA axis regulation (Jankord and Herman, 
2008), this finding may be significant, with respect to suppressed stress responses in late 
pregnancy. It is not known if similar changes in GABAA receptor subunit composition occur 
in pregnancy in other brains regions known to influence activity of the HPA axis.  
3. OXYTOCIN 
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Oxytocin is a nonapeptide, similar to vasopressin, which is produced in mammals, almost 
exclusively (Russell and Leng, 1998). Oxytocin has an important role in promoting uterine 
contractions during parturition and an essential role in stimulating ejection of milk to the 
suckling young in lactation, so it is critical for the survival of mammals. 
Oxytocin, like vasopressin, is produced in the brain, in the hypothalamus, in two types of 
neurone: the oxytocin magnocellular neurones (MCNs), located in the PVN and supraoptic 
nuclei (SON), and the parvocellular oxytocin neurones, also located in the PVN (Fig. 6). These 
two types of oxytocin neurone, distinguished by the relative sizes of their perikarya, indicate 
their different roles and relative capacities for synthesising and storing oxytocin. The 
magnocellular neurones project their axons to the posterior pituitary gland, where oxytocin 
is secreted into the systemic circulation. For its roles in parturition and lactation, oxytocin is 
secreted in response to distension of the birth canal and suckling by the young respectively, 
which strongly excite the oxytocin MCNs. Near the end of pregnancy the reflex mechanisms 
that trigger oxytocin secretion for birth become potentially more excitable (wound-up), and 
premature stimulation of secretion of oxytocin can lead to preterm birth. It has become 
clear that allopregnanolone has important actions which prevent such premature activation; 
these actions are both direct on the magnocellular oxytocin neurones, and indirect, via 
actions on inputs, including via endogenous opioids. This section provides an account of 
adaptations in the control of oxytocin neurones in pregnancy as the context for explanation 
of the importance of maintaining quiescence of oxytocin neurones in late pregnancy, and 
for the multiple inhibitory actions of allopregnanolone in this regulation, through 
interactions with specific neural inputs.          
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3.1. Functional organisation 
3.1.1. Magnocellular oxytocin neurones 
The several thousand oxytocin MCNs are classical neurosecretory neurones, each projecting 
an axon to the posterior pituitary gland (Fig. 6) where the thousands of terminals per axon 
store large amounts of oxytocin in secretory vesicles (Hatton, 1990; Katoh et al., 2010). This 
oxytocin is released by exocytosis when action potentials initiated at the axon hillock at the 
soma invade the terminals, which are adjacent to blood capillaries. Hence, in the posterior 
pituitary gland oxytocin enters the blood capillaries and is distributed in the general 
circulation, acting on peripheral targets expressing oxytocin receptors (OTR). The OTR is a 
seven transmembrane domain G-protein coupled receptor.  There is only a single oxytocin 
receptor gene (Inoue et al., 1994), which is highly expressed by the myometrium in late 
pregnancy (Kimura et al., 1992; Larcher et al., 1995; Tence et al., 1990) and by the 
myoepithelial cells of the mammary glands in lactation (Breton et al., 2001; Soloff and 
Wieder, 1983). 
 
However, in addition to release from the posterior pituitary gland, some SON oxytocin 
MCNs project axons centrally, to the central amygdala, which expresses OTR, hence 
providing a route and a mechanism for these neurones to influence emotionality by direct 
central actions (Knobloch et al., 2012). The importance of this mechanism is yet to be 
evaluated. 
A further mechanism by which MCNs can release oxytocin into the brain is via their 
dendrites, which contain substantial stores of oxytocin that can be released by exocytosis. 
This mechanism is well-established to be essential for co-ordinating the activity of the 
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oxytocin MCNs during parturition and lactation, as discussed below (see Section 3.5.). 
Release of oxytocin by MCN dendrites is also considered to be a mechanism for potential 
volume transmission in the brain, in the regulation of behaviours, including maternal 
behaviour, eating and salt ingestion (Ludwig and Leng, 2006). 
3.1.2. Parvocellular oxytocin neurones 
These neurones are found in the dorso-medial pPVN, and in more rostral contiguous 
regions, including the medial preoptic area (MPOA) (Tsuneoka et al., 2013). These neurones 
project axons within the brain, although these are generally sparse, including to the 
brainstem (Blevins et al., 2004; Stern and Zhang, 2003).  More rostral projections are 
concerned with social affiliative actions of oxytocin, and especially with the initiation of 
maternal behaviour, through actions in the olfactory bulbs, ventral tegmental area, MPOA 
and other areas (Numan and Stolzenberg, 2009; Pedersen et al., 1994). It is not yet clear 
whether allopregnanolone acts on parvocellular oxytocin neurones; this discussion will focus 
on allopregnanolone actions on the oxytocin MCNs. 
3.2. Adjustment of oxytocin neurone activity in pregnancy  
3.2.1. Preparations for birth and motherhood 
3.2.1.1. Parturition 
Oxytocin is the most potent stimulator of uterine contractions known, and is most effective 
at the end of pregnancy, when OTR expression in the myometrium is maximal, and it is 
widely used clinically to promote birth. Hence, a role for endogenous oxytocin in promoting 
parturition by stimulating uterine contractions was proposed long ago, and this is supported 
by extensive studies that have shown increased oxytocin secretion during births (Douglas et 
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al., 2002b; Fuchs et al., 2001; Gilbert et al., 1994; Higuchi et al., 1986; Lawrence et al., 1992), 
slowing of births by administering an oxytocin antagonist (Antonijevic et al., 1995), 
activation of oxytocin MCNs and their inputs from the birth canal and brainstem relays 
during parturition (Douglas et al., 2002b; Douglas et al., 1998b; Lin et al., 1998; Luckman, 
1995) and, that inhibition of oxytocin MCNs interrupts births (Russell et al., 1989). 
During parturition, oxytocin secretion is stimulated by neural afferents signalling distension 
of the birth canal (uterine cervix and vagina) (Fig. 7). As oxytocin stimulates uterine 
contractions that impel the fetus(es) towards and through the cervix, the consequent 
increased distension of the birth canal excites further oxytocin secretion: hence a positive 
feedback loop (the Ferguson reflex) drives oxytocin secretion during parturition, which is 
relaxed after the birth of each fetus and placenta (Higuchi et al., 1986). Importantly, during 
the expulsive phase oxytocin neurones fire in bursts (Fig. 7), which results in pulses of 
oxytocin secretion that are most effective in stimulating expulsive uterine contractions 
(Summerlee, 1981). In addition, there is increased oxytocin secretion between births (Leng 
et al., 1988). 
Despite all this evidence mice with engineered oxytocin or OTR gene inactivation give birth 
normally, although in normal wild-type mice oxytocin MCNs are activated in parturition 
(Nishimori et al., 2002; Nishimori et al., 1996; Young et al., 1996). Hence, oxytocin is not 
indispensable for parturition (at least in mice) and other mechanisms are involved. 
However, human studies show that threatened preterm birth can be delayed by oxytocin 
antagonist treatment (Tsatsaris et al., 2004), confirming the importance of oxytocin. 
Altogether, it is evident that inhibitory mechanisms are expected to prevail in pregnancy to 
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prevent preterm activation of oxytocin secretion, and premature births. Allopregnanolone 
has important roles in ensuring that oxytocin MCNs are restrained during late pregnancy. 
3.2.1.2. Lactation 
The essential role of oxytocin in stimulating milk ejection, or let-down, begins at birth, and is 
sustained throughout lactation. As in parturition, the secretion of oxytocin during suckling is 
part of a positive feedback loop, but now stimulation of the nipples by the suckling young 
activates neural pathways to the oxytocin MCNs in the hypothalamus resulting in 
intermittent burst-firing of the neurones, co-ordinated among the oxytocin MCNs in the 
PVN and SON (Belin and Moos, 1986; Poulain and Wakerley, 1982; Rossoni et al., 2008). 
Each burst of electrical activity, every few minutes during suckling, leads to secretion of a 
pulse of oxytocin from the posterior pituitary gland, which then stimulates a sharp increase 
in intramammary pressure that causes milk transfer into the mouths of the suckling young 
(Wakerley and Lincoln, 1973). Apart from during parturition, this pattern of oxytocin 
secretion is only seen during suckling in lactation. The mechanisms of this co-ordinated 
intermittent burst-firing of oxytocin neurones in lactation, and by inference in parturition, 
are discussed below (see Section 3.3). 
 
All other stimuli that excite oxytocin neurones do so by increasing the continuous irregular 
firing pattern of these neurones, which are not co-ordinated among the oxytocin MCNs, and 
thereby results in a steady increase in oxytocin secretion (Leng et al., 2001; Leng et al., 
1999). Allopregnanolone imposes inhibition on this type of activity of oxytocin MCNs during 
late pregnancy, as detailed below. 
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3.2.4. Restraining oxytocin neurones in pregnancy 
 
A focus in the above considerations has been an expectation of up-regulated inhibitory 
mechanisms on oxytocin neurones in pregnancy, especially to prevent preterm births by 
premature activation near the end of pregnancy. In addition, restriction of oxytocin release 
in pregnancy will permit accumulation of an increased store (about 75% increase in 
pregnancy) of oxytocin in the posterior pituitary gland, of which about 30% will be secreted 
during parturition (Douglas et al., 1993b; Fuchs and Saito, 1971). This restriction is 
important as overall, increased oxytocin mRNA expression in pregnancy relative to pre-
pregnancy has not been found (Bealer et al., 2010; Douglas et al., 1998b; Russell et al., 
2003). The possible actions of the high levels of 17β-estradiol, progesterone and 
allopregnanolone in late pregnancy on oxytocin gene expression in MCNs have been 
investigated in several studies. However, the oxytocin gene promoter lacks a typical 
estrogen response element (Handa et al., 2011; Koohi et al., 2005; Wehrenberg et al., 1994), 
and in the rat oxytocin MCNs lack ERα but express ERβ (Hrabovszky et al., 1998; Sharma et 
al., 2012; Simerly et al., 1990); whether this is important in pregnancy is not clear. Oxytocin 
MCNs do not express PR (Francis et al., 2002), yet treatment with 17β-estradiol and 
progesterone to simulate pregnancy levels, followed by withdrawal of these steroids 
increases oxytocin mRNA levels in the PVN and SON, as happens after parturition (Blyth et 
al., 2000; Douglas et al., 1998b). Strikingly, this effect of estrogen and progesterone 
withdrawal is blocked by treatment with allopregnanolone, indicating an important action 
of allopregnanolone to restrain oxytocin mRNA expression in late pregnancy, evidently via 
GABAA receptors (Blyth et al., 2000). 
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3.3 Mechanisms of restraint on oxytocin neurones in pregnancy 
The enhanced inhibitory mechanisms on oxytocin MCNs in pregnancy are superimposed on 
pre-existing neural inputs to the neurones, and include: up-regulated auto-inhibition by 
nitric oxide (NO) (Srisawat et al., 2000); emergence and action of endogenous opioid 
inhibition (Douglas et al., 1998a); allopregnanolone action on GABAA receptors (Brussaard 
and Herbison, 2000) and on the activation of pENK-A expression in the input from the NTS 
(Fig. 8)(Brunton et al., 2012; Brunton et al., 2009).  
These mechanisms show changes in relative importance as pregnancy progresses, with 
actions of allopregnanolone becoming predominant near the end of pregnancy (Fig. 8). 
Some of these mechanisms have been studied in relation to release of oxytocin in the brain, 
but most information has been obtained from studies on the oxytocin MCNs that project to 
the posterior pituitary gland. However, the oxytocin MCNs can contribute importantly to 
central oxytocin actions via release from sparse centrally projecting axons or from 
dendrites: such dendritic release of oxytocin is critically important in the local co-ordination 
and triggering of bursting activity during suckling (Lambert et al., 1993) and during 
parturition (Jiang and Wakerley, 1995; Neumann et al., 1993). Indeed, inhibiting this central 
action of oxytocin during parturition slows births (Neumann et al., 1996). 
Analysis of the functional impact of the different factors restraining oxytocin MCNs in 
pregnancy, and their mechanisms, has been based on use of a range of techniques: 
electrophysiology, gene expression measures, manipulation of gene expression, in vivo 
neuropharmacological and microdialysis studies, and these techniques have been applied to 
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the investigation of the roles and mechanisms of action of allopregnanolone on MCN 
oxytocin neurones in pregnancy. 
 
3.3.1. Identifying oxytocin neurones 
 
Electrophysiological studies depend on identifying the oxytocin MCNs as projecting to the 
posterior pituitary gland. This involves using antidromic stimulation (from the pituitary stalk) 
while recording action potentials in the SON or PVN, and the criteria of constant latency, 
high frequency following and collision by spontaneous spikes, together with a continuous 
irregular firing pattern (Leng et al., 2001; Leng and Dyball, 1991). In addition, oxytocin, but 
not vasopressin MCNs are excited by systemic cholecystokinin (CCK) administration (Renaud 
et al., 1987). For in situ histochemical studies oxytocin neurones are readily identifiable with 
immunocytochemistry or in situ hybridisation by their content of oxytocin protein or mRNA, 
respectively. 
 
3.4. Neural pathways to oxytocin MCNs 
3.4.1. Anatomically defined pathways 
3.4.1.1. Caudal inputs  
The major input relevant to pregnancy and parturition is from the brainstem, especially 
from the NTS (Fig. 6) (Raby and Renaud, 1989). This monosynaptic input conveys excitatory 
signals via somatic afferents from the birth canal (uterine cervix and vagina, as in parturition 
(Luckman, 1995; Ortega-Villalobos et al., 1990)) and from the mammary glands (nipples, as 
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during suckling in lactation (Li et al., 1999)), and signals carried by vagal afferents from the 
gastrointestinal tract (e.g. CCK, secretin, leptin: acting on vagal afferent terminals, and 
signalling on-going digestion, and satiety (Luckman et al., 1993; Onaka et al., 1995a; Renaud 
et al., 1987; Velmurugan et al., 2010). Neurones in the NTS that project to oxytocin MCNs 
are also activated by IL-1β, a cytokine produced by macrophages in response to infection 
(Ericsson et al., 1994). As discussed further below, the NTS is an important hub for inhibitory 
actions of allopregnanolone on excitatory input to oxytocin MCNs in late pregnancy. 
 
3.4.1.2. Rostral inputs 
Rostral projections from the lamina terminalis (Fig. 6), (Leng et al., 1989) confer 
responsiveness of oxytocin MCNs to increases in blood osmolarity, interacting with their 
direct osmosensitivity (reflecting the natruiretic actions of oxytocin) (Leng et al., 2001; 
Bourque, 2008), and mediate relaxin effects in pregnancy. 
3.4.1.3. Intrahypothalamic inputs 
Arcuate nucleus neurones, in the mediobasal hypothalamus that express neuropeptide Y 
(NPY) and agouti-related peptide (AgRP) (Atasoy et al., 2012), and neurones expressing pro-
opiomelanocortin (POMC: precursor for β-endorphin, an opioid peptide; and α-melanocyte 
stimulating hormone, αMSH) also project to oxytocin MCNs (Douglas et al., 2002a; Eckel et 
al., 2002) (Fig 6).  
3.4.2. Neurotransmitters/modulators 
GABAergic input is an important locus for allopregnanolone modulatory actions on oxytocin 
MCNs in pregnancy, as discussed below (see Section 3.6.2). Rostral input from the lamina 
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terminalis is important in regulating the continuous activity of oxytocin MCNs under basal 
conditions, and this is the result of the balance of excitatory glutamatergic and inhibitory 
GABAergic synaptic activity (Leng et al., 2001), the latter providing a target for direct 
allopregnanolone actions on oxytocin MCNs. 
The NTS provides direct excitatory noradrenergic input from A2 neurones, acting via α-1 
adrenoceptors (Douglas et al., 2001; Herbison et al., 1997). This input is activated during 
parturition and mediates the afferent arm of the Ferguson reflex (Meddle et al., 2000) (Fig. 
7). The noradrenergic input to oxytocin MCNs is also activated during suckling, though 
whether noradrenaline is the neurotransmitter that triggers the events leading to bursts is 
not clear (Bailey and Wakerley, 1997). This input also mediates excitatory actions of 
systemic CCK, secretin and IL-1β (Meddle et al., 2010), but these stimuli do not cause burst-
firing. In addition, NTS neurones projecting to the oxytocin MCNs express several 
neuropeptides that stimulate (e.g. NPY (Brunton et al., 2006a; Lawrence et al., 1998), 
prolactin releasing peptide (Yamashita et al., 2013)) or inhibit these MCNs (e.g. β-endorphin 
(Appleyard et al., 2005; Bronstein et al., 1992), enkephalins (Brunton et al., 2005), 
somatostatin (Meddle et al., 2010; Sawchenko et al., 1988)). Of these the enkephalins, as 
opioid peptides, are of particular importance in restraining oxytocin MCNs in pregnancy. 
Moreover, allopregnanolone action in the NTS is important in up-regulating inhibitory opioid 
expression in NTS neurones in pregnancy, as discussed below (see Section 3.8.5.). 
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3.5. Auto-regulation of oxytocin MCNs 
3.5.1. Soma and dendrites 
When stimulated, oxytocin MCNs release not only oxytocin from their soma and dendrites, 
but produce and release NO and endocannabinoids (eCB). These act to modulate 
transmitter release from the axon terminals of inputs in the dendritic microenvironment of 
the oxytocin MCNs (Fig. 8). 
3.5.2. Nitric oxide 
NO is produced by the action of neuronal nitric oxide synthase (nNOS), which oxytocin 
MCNs express, and after release NO increases local GABA release and inhibits oxytocin 
MCNs by a direct action (Stern and Ludwig, 2001). In general NO acts by stimulating cGMP 
production (Vacher et al., 2003), but this may not be the pathway in oxytocin MCNs 
(Kadekaro, 2004). Oxytocin MCNs have an increased capacity to produce NO in late 
pregnancy (Fig. 8), attributed to stimulation by prolactin via action of dendritically released 
oxytocin (Popeski et al., 2003). However, near the end of pregnancy, NO becomes less 
important as a restraint on oxytocin MCNs because their expression of nNOS mRNA is 
decreased, and NO activity is decreased (Srisawat et al., 2000). Hence, other inhibitory 
mechanisms, especially allopregnanolone and associated endogenous opioid mechanisms 
become predominant. 
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3.5.3. Endocannabinoids 
Excitation of oxytocin MCNs results in release of eCBs by the dendrites, which then act via 
cannabinoid type 1 receptors (CB1) on glutamatergic and GABAergic axon terminals, 
inhibiting both glutamate and GABA release (Hirasawa et al., 2004). Oxytocin released from 
dendrites acts as a stimulus to eCB release, which then mediates inhibitory oxytocin actions 
on glutamatergic and GABAergic terminals (Oliet et al., 2007). Such mediation by eCBs is 
supposed to aid co-ordination of burst-firing by oxytocin MCNs in parturition and lactation 
(Hirasawa et al., 2004; Oliet et al., 2007). It is not known whether eCB mechanisms are 
attenuated at the end of pregnancy, but if this happens, then a separate excitatory action of 
oxytocin on glutamatergic terminals would predominate, favouring the triggering of 
oxytocin bursts. Another auto-excitatory action of oxytocin released from dendrites is to 
desensitise GABAA receptors on oxytocin MCNs to allopregnanolone (Koksma et al., 2003) 
(see Section 3.7). 
 
3.5.4. Axon terminals in the posterior pituitary 
A κ-opioid receptor-mediated mechanism acting on the neurosecretory terminals of 
oxytocin MCNs in the posterior pituitary is activated when oxytocin secretion is increased by 
stimuli that act by simply increasing the irregular, continuous mode of firing action 
potentials. The endogenous opioid involved is likely to be an enkephalin derived from pENK-
A produced by the oxytocin neurones and released with oxytocin (Leng et al., 1994). This 
mechanism is progressively down-regulated in the last week of pregnancy, which has the 
consequence of permitting action potentials generated in the cell bodies of oxytocin 
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neurones to be more faithfully transduced into oxytocin secretion (Douglas et al., 1993b). 
Hence, restraint of oxytocin secretion by actions of allopregnanolone-dependent 
mechanisms at the level of oxytocin MCNs becomes of predominant importance near the 
end of pregnancy.  
An additional opioid mechanism has been described, mediated by µ-opioid mechanisms in 
the oxytocin terminals in the posterior pituitary; this mechanism inhibits voltage-gated Ca2+ 
channels, and could operate to modulate bursts of oxytocin secretion, as occur during 
parturition and suckling (Ortiz-Miranda et al., 2010). 
 
3.6. Hormones and inputs in pregnancy 
The corpora lutea have a major restraining action on oxytocin MCNs through the peripheral 
actions of progesterone, and the central actions of allopregnanolone, produced in large 
amounts in pregnancy. Allopregnanolone has three types of action on oxytocin MCNs: it acts 
as a positive allosteric modifier at GABAA receptors on these oxytocin neurones, enhancing 
inhibition of both electrical activity and oxytocin gene expression, and it induces opioid 
inhibition of their activity. 
3.6.1. Progesterone, allopregnanolone and the timing of parturition 
In many species, in which the corpora lutea are the major source of progesterone in 
pregnancy, the induction of luteolysis (by the fetus(es)) and consequent withdrawal of 
progesterone secretion initiates uterine contractions and precipitates parturition. 
Progesterone withdrawal enables expression of functioning OTR in the myometrium (Fuchs 
et al., 1983; Grazzini et al., 1998; Murata et al., 2000), so that reflex stimulation of oxytocin 
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secretion via the Ferguson reflex pathway activates the positive feedback mechanism (Fig. 
7) (Russell et al., 2003). Hence, preventing progesterone withdrawal at term delays births. 
This involves sustained action of progesterone not only on the myometrium, but also on the 
nodes in the Ferguson reflex pathway (Fig. 7). This is revealed by the finding that 
intravenous oxytocin injections in progesterone-treated pregnant rats at term do not 
activate NTS neurones or oxytocin MCNs, as assessed by lack of stimulation of Fos 
expression (Fig. 7)(Antonijevic et al., 2000). However, tested at increasing intervals after 
withdrawal of progesterone treatment, a progressive activation of nodes in the Ferguson 
reflex pathway is evident: i.e. stimulation of uterine contractions and births by oxytocin 
injections precedes restoration of activation of NTS neurones, which precedes activation of 
oxytocin MCNs (Antonijevic et al., 2000). Importantly, these findings indicate that the delay 
to the onset of parturition by sustained high progesterone levels is a result of actions not 
only on the myometrium, but also on the noradrenergic A2 neurones in the NTS and the 
oxytocin MCNs (Fig. 7). However, the actions of progesterone on these neurones are not 
direct and via classical PR as only scarce NTS neurones express PR, and oxytocin MCNs are 
devoid of PR (Antonijevic et al., 2000; Francis et al., 2002).  
Instead, there is substantial evidence that allopregnanolone mediates progesterone actions 
on the NTS A2 and oxytocin MCNs (Fig. 7). The likely importance of inhibitory actions of 
allopregnanolone on the central arc of the Ferguson reflex is indicated by finding that 
blocking allopregnanolone production with finasteride administration in the last few days of 
pregnancy in rats leads to preterm births, and increased neonatal mortality (Paris et al., 
2011a). However, it is not yet known whether this is a result of early activation of the 
Ferguson reflex with premature stimulation of oxytocin MCNs. 
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Per-vaginal progesterone treatment in pregnant women can be effective in preventing 
preterm labour in some women at heightened risk (Hassan et al., 2011). Whether this 
involves suppression of uterine cervical mechanisms that trigger myometrial contractions or 
actions of increased allopregnanolone production on the central mechanisms restraining 
oxytocin MCNs is not clear. From experiments on rats, either mechanism may delay the 
start of parturition through interrupting the afferent Ferguson reflex pathway (Antonijevic 
et al., 2000; Brunton et al., 2012; Paris et al., 2011a). 
3.6.2. Allopregnanolone and GABA actions on oxytocin MCNs in pregnancy 
As introduced above, GABAergic input to oxytocin MCNs has a central role in regulating 
their activity: about 45% of synapses on these neurones contain GABA (El Majdoubi et al., 
1997).  The importance of GABA applies with respect to both their ongoing continuous 
irregular pattern of activity (Leng et al., 2001) and their co-ordinated burst-firing during 
suckling (Moos, 1995; Voisin et al., 1995), and presumably during parturition. In addition to 
GABAergic input from the lamina terminalis osmoregulatory complex, regulating responses 
to changes in plasma osmolarity (Leng et al., 2001; Leng et al., 1999), there are GABAergic 
neurones around the PVN and SON (Cullinan et al., 2008; Theodosis et al., 1986); hence 
there are both distant and local GABAergic neurones involved in regulation of oxytocin 
MCNs. However, the identity of distant functional inputs to the local GABAergic neurones is 
unclear, but many studies have focused on the interactions between oxytocin MCNs and the 
GABAergic input (as well as the glutamatergic input). 
For instance, NO, as produced by activated oxytocin MCNs, inhibits these neurones via 
activating GABAergic synapses (Stern and Ludwig, 2001), and eCBs and oxytocin have 
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opposite actions, inhibiting GABA release (Oliet et al., 2007): hence, oxytocin neurones can 
be considered to filter inhibitory input by these retrograde actions. Another action on the 
GABAergic input is that of µ-opioids, which act presynaptically to inhibit GABA (as well as 
glutamate) release onto SON neurones; these actions are expected to decrease 
effectiveness of inputs (Honda et al., 2004), thus enhancing auto-control by oxytocin MCNs.    
Consequently, direct post-synaptic actions of allopregnanolone on GABAA receptors on 
oxytocin MCNs in pregnancy will intercede in the actions of these local presynaptic 
mechanisms involving NO, oxytocin and opioids actions on GABAergic terminals, and 
modulate their effectiveness. 
 
3.6.3. GABAA receptors on oxytocin MCNs and allopregnanolone actions 
 
As mentioned in Section 1.2., in general, GABA may act on post-synaptic or extrasynaptic 
GABAA receptors, resulting respectively in inhibition that is phasic (via inhibitory 
postsynaptic currents, IPSCs, elicited by quantal GABA release) or tonic (persistent inhibitory 
currents at ambient low levels of GABA) (Farrant and Nusser, 2005; Henderson, 2007; Herd 
et al., 2007). The GABA input to oxytocin MCNs acts via GABAA receptors on these neurones 
to induce phasic inhibitory synaptic transmission, and to regulate excitability of these 
neurones by causing tonic inhibition via extrasynaptic receptors; the tonic action is 
predominant (Jo et al., 2011; Park et al., 2006), although in these last studies SON oxytocin 
neurones were not positively identified. 
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3.6.3.1. GABAA receptor subunits 
The major isoform (in humans) comprises two α1, two β2 and a γ2 subunit surrounding the 
central Cl- channel, but there are 19 different subunits, from  different genes, that can be 
assembled into other isoforms; for example a δ subunit can replace a γ subunit (Fig. 1). 
GABA binds at the interfaces between the α and β subunit (Sigel and Steinmann, 2012). In 
general, phasic responses are mediated by receptors that include a γ2 subunit (Farrant and 
Nusser, 2005) and tonic responses by receptors with a δ subunit (Wei et al., 2003), while the 
synaptic or extrasynaptic locations are directed by the type of α-subunit in the receptor (Wu 
et al., 2012). 
 
Patterns of isoform expression show some selectivity for particular types of neurone: SON 
neurones (in male rats) express mRNAs for the α5, β, δ and γ2 subunits (in this study other 
subunits were not excluded), with lowest expression for the δ-subunit, and pharmacological 
experiments with subunit selective drugs show that α5-subunits with  γ2 subunits (i.e. a 
benzodiazepine-sensitive composition), rather than with δ subunits, are associated with 
tonic GABA action, contrasting with other types of neurone (Jo et al., 2011). Importantly, 
GABAA receptor subunit expression in SON oxytocin MCNs changes in pregnancy (these 
studies were focused on different GABAA receptor subunits than those in males cited above) 
with implications for possible altered allopregnanolone efficacy, as discussed below (Section 
3.7.).  
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3.6.3.2. Allopregnanolone and other allosteric modifiers  
Several drugs positively modulate activation of GABAA receptors by GABA, including 
barbiturates and benzodiazepines, and allopregnanolone is an endogenous modifier, which 
acts on different sites from these drugs, in the transmembrane regions of the α and β 
subunits (Belelli and Lambert, 2005; Hosie et al., 2006). Furthermore, δ- and γ-subunits are 
important for allopregnanolone action (Shu et al., 2012; Zheleznova et al., 2008). 
Importantly, allopregnanolone acts as an allosteric modifier on the GABAA receptors 
expressed by oxytocin MCNs (Koksma et al., 2003). Initial electrophysiological studies on 
SON oxytocin neurones showed that allopregnanolone acts via a G-protein mechanism 
involving protein kinase C to delay the closure of the Cl- channel after activation (Brussaard 
and Koksma, 2003).  It is now clear that allopregnanolone enhances both the tonic and 
phasic actions of GABA in SON neurones, but with a greater effect on current via tonic than 
phasic GABAA receptor actions, in male rats (Jo et al., 2011). As the tonic actions in SON 
neurones are predominantly via GABAA receptors containing γ2-subunits this is a contrast 
with actions on tonic GABA-mediated inhibition in other types of neurone, which is via 
GABAA receptors containing δ-subunits (Stell et al., 2003). 
 
3.7. Changes in allopregnanolone action in pregnancy 
 
As allopregnanolone levels in the brain are high in pregnancy, and decrease at the end of 
pregnancy after progesterone secretion collapses (Concas et al., 1998), a possible role for 
allopregnanolone in directly restraining oxytocin MCNs from premature activation has been 
examined in several studies. 
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Early descriptions of GABAA receptor subunit expression in SON oxytocin MCNs in female 
rats reported predominant expression of α1, α2, β2 and γ2 subunits (Fenelon et al., 1995). 
Electrophysiological studies showed that allopregnanolone effectively enhances inhibition 
by GABA in late pregnancy, but remarkably this action is lost at the end of pregnancy 
(Brussaard et al., 1997), which would be expected to permit stimulation of the neurones 
through the Ferguson reflex pathway once local uterine mechanisms initiate contractions. 
The effectiveness of allopregnanolone in late pregnancy was attributed to increased α1 
subunit expression relative to α2 expression, and the loss of allopregnanolone action at the 
end of pregnancy was initially attributed to reversal of this change in GABAA receptor 
subunit composition (Brussaard and Herbison, 2000). However, further investigation of the 
roles of oxytocin released from the dendrites of MCNs led to another explanation, which is 
that such oxytocin acts on OTR on the oxytocin neurones, with consequent activation of an 
OTR signalling pathway, leading to increased intracellular protein kinase C level relative to 
serine/threonine phosphatase and consequent phosphorylation of GABAA receptors and 
loss of their sensitivity to allopregnanolone (Koksma et al., 2003). Importantly, the change in 
GABAA receptor subunit composition at the end of pregnancy does not impact on the 
desensitisation of the receptor to allopregnanolone induced by oxytocin action (Koksma et 
al., 2003). Hence, dendritic release of oxytocin known to occur in the SON during parturition 
is expected to increase excitability of the oxytocin MCNs, as a further contributor to positive 
feedback at this time (Neumann et al., 1993). By contrast, the impairment of established 
parturition by infusion of an oxytocin antagonist into the SON may act by blocking the 
attenuation of action of allopregnanolone on GABAA receptors that increases excitability of 
the oxytocin MCNs (Neumann et al., 1996). 
43 
 
A further change in the GABA input and GABA signalling near the end of pregnancy is a 
significant increase in the number of GABAergic synapses on oxytocin MCNs, which plasticity 
can be induced in 17β-estradiol-treated virgin rats by central infusion of oxytocin for several 
days (Theodosis et al., 2006). Evidently associated with this change, the α-subunit 
composition of clusters of GABAA receptors is altered, with reduced numbers of receptors 
with α1-subunits (Koksma et al., 2005), which is expected to reduce sensitivity to 
allopregnanolone (Koksma et al., 2005; Koksma et al., 2003). 
3.7.1. Allopregnanolone and dendritic release of oxytocin 
Although the predominant actions of allopregnanolone on oxytocin MCNs are inhibitory and 
via GABAA receptors, a weak stimulatory action on somato-dendritic oxytocin release in vitro 
that is not via GABAA receptors has been reported (Widmer et al., 2003). The mechanism is 
not clear, but if this operates in late pregnancy this action could increase local oxytocin 
levels and contribute to oxytocin-induced changes in GABAergic synaptic input that promote 
co-ordinated burst-firing (Bealer et al., 2010; Theodosis et al., 2006). 
Overall, there are several events at the end of pregnancy that reduce effectiveness of 
GABAA receptors on oxytocin MCNs, and thereby increase their excitability: (i) 
allopregnanolone levels are in decline following the collapse of progesterone secretion; (ii) 
oxytocin is released by and acts on the oxytocin MCNs to desensitise GABAA receptors to 
allopregnanolone action; (iii) decrease in numbers of GABAA receptors with a subunit 
composition sensitive to allopregnanolone. Together, these changes support strong 
excitation of oxytocin MCNs and oxytocin secretion to drive births.  
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3.8. Allopregnanolone and emergence of opioid inhibition of oxytocin magnocellular 
neurones in late pregnancy 
3.8.1. Opioid actions on oxytocin neurones 
It is clear from in vivo and in vitro experiments that the electrical activity of oxytocin MCNs is 
exquisitely sensitive to inhibition by opioid peptides and opiate drugs.  These include 
endogenous peptides selective for µ-, κ- and δ-opioid receptors, given by 
intracerebroventricular (i.c.v.) injection, or applied in vitro to hypothalamic slice 
preparations. In vitro studies on SON MCNs, characterised as putative oxytocin-containing 
neurones from their electrophysiological properties, have shown inhibitory effects of 
endomorphin-1, a µ-opioid (Doi et al., 2001), dynorphin, a κ-opioid (Inenaga et al., 1994), 
and [D-ala, D-leu]enkephalin, a δ-opioid (Inenaga et al., 1994; Wakerley et al., 1983). In 
addition, SON oxytocin MCNs are inhibited by nociceptin, a peptide related to the opioids, 
but acting on a distinct post-synaptic opioid receptor-like (ORL1) receptor (Doi et al., 1998). 
The opiate drugs morphine (a µ-agonist), and U50,488H (a κ-agonist) inhibit putative 
oxytocin MCNs in the SON in vitro (Inenaga et al., 1994; Wakerley et al., 1983), and in vivo 
by actions in the SON (Ludwig et al., 1997; Pumford et al., 1993). The inhibitory effects of 
opioids involve actions directly on oxytocin MCNs (Doi et al., 2001; Inenaga et al., 1994; 
Johnstone et al., 2000), and presynaptic actions in the SON, on excitatory glutamatergic 
input (Honda et al., 2004; Inenaga et al., 1994), while the inhibition by morphine of the 
stimulation of oxytocin MCNs by i.v. CCK (Pumford et al., 1993) involves presynaptic actions 
in the SON on the noradrenergic input from the NTS (Onaka et al., 1995b). 
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The impact of the powerful inhibitory actions of opioids on the electrical activity of oxytocin 
MCNs on function is indicated by the strong effects of opiates on established parturition. 
Hence morphine and U50,488H, given once births have started, greatly delay the next birth, 
by central actions on oxytocin secretion (Douglas et al., 1993a; Russell et al., 1989). 
3.8.2. Chronic opioid action on oxytocin neurones 
Active inhibition by endogenous opioid peptides is revealed by increased oxytocin secretion 
or firing rate of oxytocin MCNs following administration of an opioid receptor antagonist. In 
non-pregnant rats naloxone does not affect firing-rate of SON oxytocin MCNs, but naloxone 
administration in the last 3 days of pregnancy increases basal oxytocin secretion, which is 
not attributable to actions in the posterior pituitary gland (Douglas et al., 1993b). Moreover, 
naloxone (but not nor-binaltorphimine, a specific κ-opioid receptor antagonist), activates 
Fos expression in SON neurones and increases somatodendritic release of oxytocin in the 
SON only in rats in late pregnancy (Douglas et al., 1995). Hence, in late pregnancy, central 
endogenous opioid inhibition of oxytocin MCNs emerges, and is likely mediated by µ-opioid 
receptors (Fig 8).  
A striking finding from studies of effects of chronic opiate exposure on oxytocin MCNs is 
that they develop dependence during central morphine (a µ-agonist) administration for 
several days, as revealed by strong and prolonged excitation of electrical and secretory 
activity immediately following naloxone injection (Bicknell et al., 1998; Brown and Russell, 
2004). This withdrawal excitation is partly attributable to mechanisms in the oxytocin MCNs, 
including altered mechanisms that govern excitability after each spike, specifically inhibition 
of K+ channels and enhanced after-depolarization amplitude (Brown at al., 2005; Bull et al., 
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2011; Ruan et al., 2011), and is partly attributable to activation of the input from the A2 
noradrenergic neurones in the NTS (Murphy et al., 1997; Brown et al., 1998). These changes 
have some similarities with changes in the activity of oxytocin MCNs and the NTS projection 
to the neurones at the end of pregnancy. At this time more oxytocin MCNs show 
depolarising after-potentials (Teruyama and Armstrong, 2002), and release of noradrenaline 
in the SON in response to CCK is facilitated (Tobin et al., 2010). Consequently, it may be that 
chronic exposure to endogenous opioid in late pregnancy not only inhibits the oxytocin 
MCNs, but results in enhanced excitability when the opioid action is withdrawn. However, 
direct evidence for this is presently lacking (Doi et al., 2001).    
Key issues about the opioid inhibition of oxytocin MCNs that emerge in late pregnancy to be 
addressed here are: (i) its functional importance; (ii) the source of the opioid(s); (iii) whether 
it acts selectively on specific inputs; and (iv) allopregnanolone action as the mechanism that 
activates the opioid inhibition of oxytocin MCNs in late pregnancy.  
3.8.3. Functional importance in pregnancy 
 
Importantly, naloxone reverses attenuated oxytocin responses to several stimuli that are 
conveyed by the brainstem NTS pathway to oxytocin MCNs and simulate activation of the 
Ferguson reflex pathway in parturition. Stimulation of oxytocin MCNs by such stimuli that 
increase their electrical activity and thence oxytocin secretion without pregnancy are much 
less effective in late pregnancy, and naloxone restores, or in some cases exaggerates 
responses. The emergence of opioid inhibition of oxytocin MCN responses in late pregnancy 
can be viewed as a mechanism that potentially prevents premature activation of the 
positive feedback loop (Ferguson reflex) that promotes parturition. While oxytocin secretory 
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responses to forced swimming, an emotional and physical stressor, are similar between 
virgin and late pregnant rats,  treatment with naloxone before swimming reveals a much 
greater response in the pregnant rats; this indicates strong opioid inhibition of a latent 
greater response in pregnancy (Douglas et al., 1998a). To explore further, this emergent 
opioid restraint of oxytocin MCNs has been investigated by using stimuli known to stimulate 
the NTS A2 noradrenergic projection, similar, if not identical with  that which is importantly 
activated in parturition (Meddle et al., 2000). 
3.8.3.1. CCK as a stimulus 
Endogenous opioid inhibition has been demonstrated in late pregnancy for responses to i.v. 
CCK, which normally acts to excite oxytocin MCNs via vagal afferents to the noradrenergic 
A2 neurone projection from the NTS to the SON and PVN (Onaka et al., 1995a; Ueta et al., 
2000). Hence, in anaesthetised rats prepared for in vivo electrophysiological recording of 
SON oxytocin MCN activity, administration of naloxone before CCK in late pregnancy (day 
21, with start of pregnancy designated day 0) increases the firing-rate response to CCK, but 
has no effects in early pregnancy or in virgin rats (Douglas et al., 1995). Evidently, at the late 
stage of pregnancy the effectiveness of this noradrenergic input is potentially enhanced, but 
opioid restraint conceals this potential, and should guard against untimely stimulation of 
oxytocin neurones in late pregnancy. Moreover, at term, on the day of expected parturition 
(day 21 or 22, with the first day counted as day 0 in this study), even without antagonising 
opioid inhibition the release of noradrenaline in the dorsal SON, where oxytocin neurones 
predominate, is greater in response to i.v. CCK than on day 20, or in virgin rats (Tobin et al., 
2010). This finding indicates that any presynaptic opioid inhibition of noradrenaline release 
in the SON is lost in the last 24-48h before parturition; however this needs to be tested by 
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giving naloxone before CCK. Furthermore, this finding indicates that in this last 24-48h 
before parturition the opioid-mediated restraint of oxytocin MCN responses to i.v. CCK 
found in late pregnancy (day 21) includes post-synaptic opioid inhibition of oxytocin MCN 
excitability at this time. Nonetheless, antidromic electrical stimulation of oxytocin MCNs 
reveals underlying enhanced excitability near the end of pregnancy, and this is accompanied 
by increased noradrenaline release in the dorsal SON, perhaps a result of action of 
dendritically released oxytocin on noradrenergic terminals (Tobin et al., 2010); whether this 
can be further enhanced by antagonism of the endogenous opioid inhibition remains to be 
tested. This increased excitability of oxytocin MCNs demonstrated in vivo near the end of 
pregnancy may be related to the increased depolarising after-potentials (DAPs) that these 
neurones express at this time (Teruyama and Armstrong, 2002).  
The population of A2 neurones that are excited by CCK is unlikely to be the same as the 
population that is activated during parturition to drive the release of oxytocin (Bailey and 
Wakerley, 1997). However, activation of oxytocin neurones by any noradrenergic neurones 
could potentially initiate uterine contractions, activate the Ferguson reflex and thence 
trigger preterm births, given that the myometrium is sensitive to oxytocin via increased 
expression of OTR. Hence, opioid inhibition of the A2 noradrenergic input, induced by 
allopregnanolone as discussed below, is expected to be important in preventing such 
premature births. 
3.8.3.2. IL-1β as a stimulus 
Administration of IL-1β mimics activation of macrophages by infection, and utero-cervical 
infection in pregnancy is proposed as a factor in preterm labour and birth (Klein and Gibbs, 
2005). While such infection has local effects, released  IL-1β can enter the circulation and 
49 
 
signal to the brain (Rivest et al., 2000), and the NTS in particular, by acting on interleukin 
receptors expressed on endotheial cells lining blood vessels in the dorsal medulla oblongata 
(Ek et al., 2000). Activation of these interleukin receptors triggers, via cyclo-oxygenase, local 
production of prostaglandins, which diffuse locally to act on prostaglandin receptors 
expressed on the A2 noradrenergic neurones in the NTS (Zhang and Rivest, 1999); 
consequently oxytocin MCNs are stimulated (Ericsson et al., 1994), as are CRH neurones in 
the PVN, discussed above (Section 2.1.1.). 
Remarkably, in late pregnancy the excitation of oxytocin MCNs by i.v. injection of IL-1β is 
suppressed, as measured in identified SON oxytocin cells by electrophysiological recording 
of firing rate and by immunocytochemical detection of Fos protein expression, and by 
measurement of oxytocin secretion (Brunton et al., 2012; Brunton et al., 2006b). Together, 
these findings show that a central mechanism suppresses oxytocin MCN responses to 
systemic IL-1β in late pregnancy. 
Importantly, NTS neurones show Fos activation after i.v.  IL-1β injection in late pregnant rats 
to an extent that is indistinguishable from the activation in virgin rats (Brunton et al., 2005). 
Moreover, noradrenaline release in the PVN, which contains oxytocin MCNs, in response to 
i.v.  IL-1β injection is suppressed in late pregnancy (Brunton et al., 2005); this may explain 
the lack of Fos protein activation by IL-1β in oxytocin MCNs in the PVN in late pregnancy 
(Brunton et al., 2012), and a similar explanation is likely to apply to the lack of responses of 
SON oxytocin MCNs to IL-1β in late pregnancy, although noradrenaline release in the SON 
was not also measured in these studies.  Hence, combining these findings, it seems that the 
suppression of oxytocin MCN responses to i.v. IL-1β injection in late pregnancy is 
consequent on failure of signalling by the NTS A2 neurones to the oxytocin MCNs. By 
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contrast, it is established that A2 noradrenergic neurones project also to the CeA and 
consequently i.v. IL-1β injection activates CeA neurones (Buller and Day, 2002); in late 
pregnancy this activation of CeA neurones persists, as measured by Fos expression (Brunton 
et al., 2012). Hence, suppression of responses to IL-1β in oxytocin MCNs (Brunton et al., 
2012), and PVN CRH neurones (Brunton et al., 2005), is evidently a result of selective 
inhibition in the direct projection from the NTS to these neurones, which does not include 
the NTS projection to the CeA. 
Importantly, this selective inhibition is mediated by an endogenous opioid mechanism that 
acts presynaptically to inhibit noradrenaline release, as shown for the PVN (Fig. 5) and 
discussed above (Section 2.2.2.) in the context of PVN CRH neurones and the HPA axis 
(Brunton et al., 2005). Hence, naloxone treatment before i.v. IL-1β injection restores a firing-
rate response to IL-1β in SON oxytocin MCNs in late pregnant rats without increasing the 
response in virgin rats (Brunton et al., 2006b). Naloxone treatment also restores an oxytocin 
secretory response to IL-1β in late pregnant rats, although the increase is greater than in 
virgin rats, which reflect the enlarged oxytocin store in the posterior pituitary gland in late 
pregnancy (Brunton et al., 2006b).  
Overall,  by suppressing oxytocin secretory responses to stimuli such as CCK and IL-1β in late 
pregnancy, the central opioid mechanism, induced by allopregnanolone as discussed below,  
is considered to contribute to the enlargement of the store of oxytocin for parturition as 
well as contributing to preventing premature activation of oxytocin secretion  (Russell et al., 
2003). 
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3.8.4. Source of endogenous opioid restraining oxytocin MCNs 
Two candidate sources of opioid peptide have been studied: the NTS and the arcuate 
nucleus. 
3.8.4.1. Arcuate nucleus POMC neurones 
A projection from POMC neurones to the PVN and SON neurones is well-established 
(Douglas et al., 2002a; Kiss et al., 1984). POMC may be processed to ACTH, β-endorphin (an 
opioid peptide) and α-MSH, and of these peptides the amount of β-endorphin in the 
hypothalamus and the level of POMC mRNA in the arcuate nucleus have been reported to 
be increased in pregnancy (Wardlaw and Frantz, 1983). There is increased density of β-
endorphin-containing fibres in the SON in late pregnancy, together with an increased 
number of POMC mRNA containing neurones in the caudal arcuate nucleus (Douglas et al., 
2002a). Hence, there is potential for increased action of β-endorphin on oxytocin MNCs in 
late pregnancy. However, other studies have not found increased POMC mRNA level in the 
arcuate nucleus in pregnancy (Trujillo et al., 2011) and altered β-endorphin action on 
oxytocin MCNs in pregnancy has not been critically tested. Nevertheless, α-MSH has 
important, and complex actions on oxytocin MCNs; α-MSH inhibits the firing rate of these 
neurones while also increasing dendritic oxytocin release, and the latter action is considered 
to be important in effecting the anorectic role of α-MSH (Sabatier et al., 2003). However, 
appetite is increased in pregnancy, so reduced rather than increased activity of this α-MSH-
oxytocin mechanism is expected (Douglas et al., 2007). 
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3.8.4.2. NTS A2 neurones expressing pENK-A 
Recent evidence indicates that these neurones are responsible for the opioid inhibition of 
oxytocin MCNs that emerges in late pregnancy, as discussed next. 
 
3.8.5. Induction of opioid inhibition in late pregnancy by allopregnanolone 
 
3.8.5.1. Sex steroids 
Initial study of the induction in late pregnant rats of the opioid inhibition of oxytocin 
responses to forced swimming, mentioned above (Douglas et al., 1998a), used combined 
17β-estradiol and progesterone treatment of virgin rats, to mimic changes in these steroids 
in pregnancy. This study found that in rats given this treatment and exposed to forced 
swimming, oxytocin secretory responses were enhanced more by naloxone than in virgins 
not given female sex steroids (Douglas et al., 2000). However, in late pregnant rats naloxone 
alone increases Fos expression in oxytocin MCNs (Douglas et al., 1995) but in the estradiol 
and progesterone treated virgins naloxone did not increase Fos expression in the SON 
(Douglas et al., 2000): hence the sex steroid treatment evidently did not induce the central 
endogenous opioid inhibition over oxytocin MCNs that is seen in late pregnancy. This led to 
studying a possible role for allopregnanolone (Fig 7). 
 
3.8.5.2. Allopregnanolone manipulations 
In parallel with studies on the induction by allopregnanolone of opioid inhibition of PVN CRH 
neurones and the HPA axis (see Section 2.2.) (Brunton et al., 2009), study of the actions of 
allopregnanolone in virgin rats and of finasteride, to block allopregnanolone production, in 
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late pregnant rats has provided evidence for a key role for allopregnanolone in inducing 
opioid inhibition of oxytocin MCNs in late pregnancy (Brunton et al., 2012). Hence, 
overnight treatment of late pregnant rats (from day 20 to 21) with finasteride leads to an 
exaggerated oxytocin secretory response to IL-1β compared with the absent response to  IL-
1β in late pregnant rats not given finasteride, while finasteride has no effect on the 
response in virgin rats (Brunton et al., 2012). Conversely, treating virgin rats overnight with 
allopregnanolone suppresses the oxytocin response to IL-1β, and treating late pregnant rats 
with allopregnanolone and finasteride also suppresses oxytocin responses to IL-1β; by 
contrast, overnight treatment of virgin rats with the allopregnanolone precursors, 
progesterone or DHP has no effects (Brunton et al., 2012). The actions of allopregnanolone 
or finasteride are central, as respective decreases or increases in Fos expression in PVN and 
SON oxytocin MCNs accompany the changes in oxytocin secretion (Brunton et al., 2012). 
3.8.5.3. Allopregnanolone and opioid inhibition 
Finasteride and naloxone have similar actions in restoring oxytocin secretory responses to 
i.v.  IL-1β injection in late pregnant rats, and given together the actions of finasteride and 
naloxone are not additive (Brunton et al., 2012). This indicates that allopregnanolone acts to 
induce opioid inhibition on oxytocin neurones.  A candidate opioid is met-enkephalin, the 
content of which in the mediobasal hypothalamus is increased in late pregnancy (Petraglia 
et al., 1985). Met-enkephalin is produced from pENK-A, and pENK-A mRNA expression in the 
NTS is up-regulated in late pregnancy, and this may be the source of the increased met-
enkephalin content in the hypothalamus. Importantly, the up-regulation of pENK-A mRNA 
expression in the NTS is evidently the result of induction by allopregnanolone (Brunton et 
al., 2009; Brunton et al., 2005) (Fig. 8). 
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The expression of µ-opioid receptor mRNA in the NTS is also up-regulated in late pregnancy, 
but this is not regulated by allopregnanolone (Brunton et al., 2009). The current model 
proposed for opioid inhibition of oxytocin MCNs in late pregnancy is similar to that for PVN 
CRH neurones (Brunton et al., 2005)(see Section 2.2.2.) (Fig. 5). It is proposed that both met-
enkephalin and µ-opioid receptors are transported within the axons of NTS neurones to the 
PVN and SON, and when stimulated by IL-1β, or other factors such as CCK, the release of 
met-enkephalin would act on µ-opioid receptors inserted in the membranes of presynaptic 
noradrenergic terminals to inhibit release of noradrenaline (Brunton et al., 2005). This 
model is supported by the finding that morphine, a µ-opioid receptor agonist, inhibits 
noradrenaline release stimulated by i.v. CCK injection (Onaka et al., 1995b), and that 
microdialysis of naloxone into the PVN in late pregnant rats reverses suppressed release of 
noradrenaline in response to i.v. IL-1β injection (Brunton et al., 2005). 
 
3.8.5.4. Questions about allopregnanolone and opioid actions on oxytocin MCNs still to be 
addressed 
It is still not known: (i) how allopregnanolone induces up-regulation of pENK-A mRNA 
expression in NTS A2 neurones, though NTS neurones express GABAA receptors (Saha et al., 
2001; Terai et al., 1998), there are GABA neurones in the NTS (Bailey et al., 2008; Fong et al., 
2005; Huang et al., 2011) and GABA terminals contact enkephalin fibres in the NTS (Huang 
et al., 2011); (ii) how µ-opioid receptor mRNA expression in the NTS is up-regulated in 
pregnancy; (iii) whether up-regulated pENK-A mRNA and µ-opioid receptor mRNA are in the 
A2 noradrenergic neurones; (iv) whether pre-terminal opioid inhibition of noradrenaline 
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release operates in the SON in late pregnancy, and whether allopregnanolone treatment in 
virgin rats initiates this; (v) whether chronic action of opioid induced by allopregnanolone 
induces enhanced excitability of oxytocin MCNs when the opioid action is withdrawn at 
parturition; (v) the relative importance of actions of allopregnanolone directly on oxytocin 
MCNs in the PVN and SON versus actions on neurones in the NTS.  
 
3.9. Opioid actions during parturition 
 
While the role of opioid inhibition of oxytocin MCNs in late pregnancy is proposed to be to 
restrain activation by stimuli unrelated to the initiation of parturition, there are continuing 
roles for opioid inhibition during parturition. These are a role in regulating oxytocin 
secretion and in suspending parturition in conditions of environmental stress. 
Allopregnanolone levels fall at the end of pregnancy (Concas et al., 1998), but the time-
course of expected consequent down-regulation in opioid gene expression in the NTS has 
not been investigated. However, opioid inhibition of oxytocin MCNs is not detectable in 
lactation (Douglas et al., 1993b; Neumann et al., 1993). 
 
3.9.1. Regulation of oxytocin secretion 
 
Administration of naloxone during parturition results in further increase in oxytocin 
secretion, which has adverse effects as births are accelerated (Leng et al., 1988). As a 
consequence, intervals between births are shortened, which compromises maternal care 
and leads to increased neonatal mortality (Leng et al., 1988). Electrophysiological recordings 
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of the activity of oxytocin MCNs have not been made in these circumstances, so it is not 
clear whether the increased oxytocin secretion after naloxone during parturition is a result 
of its central action. The increase in oxytocin secretion is not a result of increased dendritic 
release of oxytocin and enhanced auto-stimulation as naloxone no longer increases this 
during parturition (Neumann et al., 1993). 
 
3.9.2. Stress during parturition 
 
In rats and pigs environmental stress during parturition (e.g. moving mothers during 
parturition from the nest to another location) slows the process and reduces oxytocin 
secretion (Lawrence et al., 1992; Leng et al., 1988). These effects of the disturbance are 
naloxone-reversible, and hence result from activation of an endogenous opioid mechanism 
(Lawrence et al., 1992; Leng et al., 1988). Whether this is the same mechanism that has 
been characterised as detailed above, in the NTS, and responsible for the allopregnanolone-
induced opioid restraint of oxytocin MCNs during late pregnancy is not clear. If so, it might 
be that during parturition the Ferguson reflex pathway may stimulate oxytocin MCNs via a 
set of A2 neurones that may not produce opioids, but be susceptible to presynaptic 
inhibition by opioid from another set of A2 neurones activated by stress. Mice that are 
exposed to environmental disturbance during parturition also respond by suspending births, 
but in this species an opioid mechanism is not involved, as naloxone has no effect, and a 
peripheral β-adrenergic mechanism is activated instead (Douglas et al., 2002b). 
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4. COMPROMISED PREGNANCY AND OFFSPRING OUTCOMES 
 
4.1. Essential roles of neurosteroids in the fetal brain 
 
The maintenance of normal gestational neuroactive steroid concentrations is essential for 
brain growth, neuronal and glial cell survival and repair after injury (Melcangi et al., 2008; 
Wang et al., 2008). We have further shown that neuroactive steroids regulate late gestation 
CNS activity and maintain normal sleep-like activity that typifies the fetal brain (Nicol et al., 
1997). Reduced allopregnanolone synthesis leads to increased excitability and susceptibility 
to hypoxia-induced excitotoxicity (Nicol et al., 2001). Deficiencies in neuroactive steroid 
levels in turn rob the fetus of a key endogenous neuroprotective mechanism and increase 
the risk of brain injury (Yawno et al., 2006). This then leads to increase apoptotic neuronal 
and glial cell death and a reduction in normal growth and repair processes. Progesterone 
has potent repair-promoting actions following traumatic brain injury in adults (Stein, 2008; 
Wright et al., 2007). While, some of this action involves the metabolism of progesterone to 
raise allopregnanolone levels (He et al., 2004), un-metabolised progesterone also promotes 
growth and potentially re-myelination (Schumacher et al., 2012).  
 
4.2. Effect of fetal growth restriction on steroid-mediated neuroprotection  
The neuroprotective action of allopregnanolone is critical in reducing fetal brain injury 
following hypoxic/ischemic insults (Nguyen et al., 2004b; Yawno et al., 2006). The finding 
that glucocorticoids may suppress allopregnanolone synthesis pathways indicates that 
chronic compromise during gestation may be more damaging due to down-regulation of 
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protective neuroactive steroid levels.  Intrauterine growth restriction (IUGR) is a condition 
where the fetus does not grow in line with its growth potential. IUGR results from placental 
insufficiency that limits nutrient supply to the fetus and in turn is considered to result from 
inadequate placental growth (Sankaran and Kyle, 2009). Consequently, birth weight is 
reduced and the fetus adapts with relative brain growth sparing.  IUGR can be seen as a 
chronic adaptation of the fetus, so the levels of stress are compensated for and fetal cortisol 
levels may not be elevated.  We have used a model of growth restriction in the guinea pig, 
in which the supply of maternal blood to the placenta is reduced to create placenta 
insufficiency during the second half of gestation.  The placental insufficiency resulted in 
asymmetric growth and brain sparing observed throughout the last third of gestation, which 
is typical of IUGR seen in human pregnancy (Falo, 2009). In contrast to previous 
observations with acute stress, we found no increase in neuroactive steroid levels after this 
chronic stress, and in the IUGR fetuses allopregnanolone concentrations were reduced in 
both plasma and brain. In addition, there was reduced expression of 5-reductase-2 in the 
brain of these fetuses (Kelleher et al., 2011). The reduced plasma levels of allopregnanolone 
suggest the synthesis in the periphery as well as the brain is reduced in IUGR. These findings 
indicate reduced allopregnanolone levels may contribute to the adverse outcomes observed 
in these pregnancies. The relative importance of the potential sources of neuroactive 
steroids remains unclear and the elucidation of the mechanism leading to deficits in 
production will be important to the understanding of processes leading to reduced 
neuroactive steroid levels in pregnancies complicated by chronic pathologies.  
Previous studies have demonstrated that suppression of allopregnanolone production by 
fetal administration of finasteride during late gestation markedly potentiates acute 
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hypoxic/ischemic injury in the fetal sheep (Yawno et al., 2006). This reduction in fetal brain 
allopregnanolone may be similar to the effect of IUGR where the adverse effect of placental 
insufficiency-induced hypoxia may be potentiated by reduced levels of allopregnanolone. 
Furthermore, the reduced expression of 5-reductase-2 in the brain of these fetuses 
suggests that IUGR may further limit their neuroactive steroid synthetic capacity in the 
immediate perinatal period following birth (McKendry et al., 2010). Such a disruption of 
neuroactive steroid synthesis or supply potentially predisposes to the vulnerability of the 
IUGR fetus to injury caused by hypoxia during birth or in the neonate immediately after 
birth.  
Finasteride treatment leading to low concentrations of allopregnanolone has been shown to 
reduce myelination in the sub-cortical white matter and tracks in the hippocampus (Kelleher 
et al., 2007).  In addition, we have shown that finasteride treatment  markedly potentiates 
the myelination deficits seen in growth restricted fetuses (Kelleher et al., 2007).  This is 
further evidence showing that neuroactive steroids continue to provide protection even in 
pregnancies complicated by chronic IUGR, however the exact pathways involved are 
unclear. Progesterone has been shown to have positive effects on myelination in the 
developing CNS, potentially by the enhancement of maturation processes whereby 
oligodendrocyte precursor cells become myelinating oligodendrocytes (Ghoumari et al., 
2003). Whilst allopregnanolone has been shown to have positive effects on myelin basic 
protein (MBP) expression, progesterone appears to be a more potent positive modulator of 
myelination. The investigation of direct progesterone-progesterone receptor effects in this 
guinea pig model of IUGR may delineate the mechanism by progesterone acts. However, 
gestational progesterone concentrations do not decline with IUGR in the guinea pigs 
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suggesting supplementation with further progesterone would be unlikely to improve the 
outcome.  Together the present observations of changes in MBP expression are consistent 
with studies that have previously indicated a trophic effect of neuroactive steroids on the 
late gestation myelination (Schumacher et al., 2000).  This supports the concept that the low 
neurosteroid levels negatively impact myelination when the endogenous steroid supply is 
disrupted.  
Several studies have evaluated maternal progesterone as a treatment to reduce the risk of 
preterm labour (Coomarasamy et al., 2006) and further analysis is ongoing (Dodd et al., 
2009), however, there are few data on effects on the fetus (Doyle, 2009). The potentially 
positive effects of increasing neuroactive steroid levels by the use of supplementation or 
replacement strategies perhaps using progesterone, in IUGR fetuses or newborns, requires 
evaluation. We have previously demonstrated suppression of allopregnanolone synthesis 
decreases markers of cell proliferation, and that the effect can be ameliorated when the 
synthetic neuroactive steroid, alfaxalone is used to replace the loss of the endogenous 
neuroactive steroid (Yawno et al., 2009).  This indicates a potential role for 
allopregnanolone treatment or supplementation with synthetic analogues in stimulating 
developmental processes in late gestation IUGR fetuses.  Alternatively a more clinically 
appropriate approach may be the treatment of neonates after birth.  
 
4.3. Adverse fetal outcomes following premature birth 
 
The observations outlined above showing that myelination is sensitive to compromised 
pregnancy led us to investigate the effect of a premature loss of neuroactive steroid 
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exposure on outcome. Previous studies have reported marked disruption of myelination 
processes due to preterm delivery.  Furthermore, the potential irreversible loss of 
myelinating oligodendrocytes can result in permanent perturbation of myelin development, 
severe white matter damage and lasting neurological effects (Kinney, 2005). Evidence from 
imaging studies in human preterm infants has shown that white matter injury and 
myelination disorders in the early postnatal period are likely to persist past the age 
equivalent to term and are not rectified by catch up growth (Inder et al., 2005). The finding 
that myelin formation and maturation are influenced by both progesterone and neuroactive 
progesterone metabolites (Baulieu and Schumacher, 2000; Ghoumari et al., 2003; Kelleher 
et al., 2011) suggests that adequate levels of neuroactive steroids in the brain may be a 
critical factor in the degree of disruption following preterm birth.  Low neuroactive steroid 
levels may therefore further disrupt the progression of normal myelination in the preterm 
neonatal brain. To date however studies have not delineated the processes that determine 
if there is a continued long-term deficit or if there is catch-up myelination.   
 
We used a guinea pig model of preterm delivery to examine the changes in neuroactive 
steroid concentrations in the circulation and neonatal brain. In these studies guinea pig 
neonates were delivered 8 days preterm and maintained for 8 days until term equivalent 
age. This work showed that microtubular associated protein-2 (MAP-2) staining, a structural 
marker of neuronal differentiation, did not differ between neonates delivered preterm and 
maintained ex utero until term equivalent age and neonates delivered at term (Kelleher, 
2013).  This suggests that there were no losses in neurones or reduction in dendritic 
branching present at 8 days of age in this model of preterm delivery. This finding may be 
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due to the relatively precocial nature of guinea pigs at term and a high degree of brain and 
neural development will have occurred earlier in gestation (Dobbing and Sands, 1979) and 
so is not affected by delivery 8 days preterm.  In contrast, we observed markedly reduced 
MBP staining in the hippocampus and subcortical white matter consistent with reduced 
myelination.  
The transition from fetal to neonatal life in this guinea pig model of preterm delivery is 
associated with a loss of placental progesterone and a decrease in allopregnanolone 
concentrations in the plasma (Fig. 9) and brain of both term and preterm neonates. This is 
consistent with previous findings showing that a loss of placental precursor supply leads to a 
consequent fall in allopregnanolone concentrations following term delivery in neonatal 
sheep (Nguyen et al., 2003).  Taken together these studies indicate that preterm delivery 
leads to a developmental period where considerable myelination is necessary to reach 
levels seen at normal term.  This development must occur in an environment in which 
neuroactive steroid levels are markedly lower than those in utero.  We further measured 
5-reductase-1 and -2 expression concurrently in the brain of neonatal guinea pigs 
following preterm birth to determine if local production of neuroactive steroids may 
compensate for the loss of the placenta. We found that 5-reductase-2 expression levels 
decline after both term and preterm birth compared to fetal levels (Fig. 10) whereas there 
was no difference in 5-reductase-1. Previous studies of allopregnanolone production in 
fetal sheep have identified 5-reductase-2 as the most important isoform in regulating 
neuroactive steroid levels within the fetal brain (Martini, 1982; Nguyen et al., 2003) and in 
controlling responses to stress (Nguyen et al., 2004a). Studies in rats have similarly shown 
that 5-reductase-2 expression is highest during development and makes a major 
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contribution to enzyme activity at this time, before declining in later life. The decline in 
expression of 5-reductase-2 in the neonatal brain after preterm birth indicates the 
possibility of local tissue levels compensation is unlikely.  These observations support the 
contention that the preterm neonatal brain develops in a neuroactive steroid deficient 
environment, and that this may contribute to the myelination deficit observed in the 
preterm neonate at term equivalent age compared to the neonate that is delivered at full 
term. 
4.3.1. Progesterone replacement in preterm neonates  
 
Progesterone concentrations in human maternal serum increase dramatically from 98 
nmol/L in mid-gestation to nearly 800 nmol/L in late gestation (Donaldson et al., 1991).  This 
represents a 7- to 9-fold increase from mid- to late gestation and is associated with 
increasing allopregnanolone levels in the maternal plasma (Gilbert Evans et al., 2005). Fetal 
concentrations of progesterone in both male and female fetuses also increase (Donaldson et 
al., 1991). Despite the high progesterone concentration in the human maternal circulation, 
preterm labour can occur because the uterine progesterone receptor systems become less 
sensitive to progesterone.  This has led to clinical studies of the use of both progesterone 
and synthetic analogues to supplement progesterone levels in attempts to prevent preterm 
birth (Mackenzie et al., 2006).  There is currently, however, little information on the effect 
of such treatments on fetal and neonatal allopregnanolone concentrations. 
4.3.1.1. Short-term progesterone treatment 
Given the role of placental progesterone in maintaining neuroactive steroid levels, we 
examined the efficacy of progesterone supplementation for in increasing allopregnanolone 
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concentrations in preterm guinea pig neonates. We demonstrated that administration of 
progesterone elevated plasma progesterone and allopregnanolone concentrations in the 
fetal plasma (Fig. 9). Despite reduced expression of 5α-reductase-2 in the brain, exogenous 
administration of progesterone at 6 hours and 12 hours after preterm birth was sufficient to 
increase allopregnanolone concentrations in the brain of the neonates at 24 hours after 
preterm birth (Kelleher, 2013). Levels reached in the neonatal brain were close to or above 
those observed during fetal life (Fig. 9).  These findings indicate progesterone is sufficient to 
augment allopregnanolone levels in the brain using endogenous synthetic mechanisms, 
allowing appropriate neuroactive steroid concentrations to become re-established following 
preterm birth. This relatively short-term administration of progesterone to preterm 
neonates did not have any effect on markers of myelination or reactive astrocytes at 24 
hours of age compared to vehicle.  However, longer-term progesterone replacement, during 
the preterm postnatal period, warrants further examination to determine the effects on 
brain development and functional neurological outcomes. 
 
Our finding that neuroactive steroid levels in the preterm neonate are at least partially 
dependent on progesterone concentrations suggest some caution is needed over the 
potential effect of treatments on brain development. Additionally, synthetic progestins may 
inhibit endogenous neuroactive steroid synthesis (Belelli et al., 2003), whilst being unable to 
be metabolized into neuroactive steroids themselves (Ciriza et al., 2004). Furthermore, our 
finding also indicates that care needs to be exercised in the dose of progesterone so as to 
avoid any potentially negative effects of excessive allopregnanolone levels in the brain. The 
changes we reported were in late gestational guinea pigs which are a clinically relevant 
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model of premature birth, with evidence of neurodevelopmental immaturity, and reduced 
myelination at the preterm gestational age examined. The findings indicate progesterone 
therapy during the postnatal period may be an appropriate approach for replacing 
neuroactive steroids and positively influencing brain maturation. There is little clinical 
evidence describing the effects of progesterone treatment of human neonates. Pilot trials 
have been performed in extremely preterm neonates. Studies have examined the effects of 
postnatal replacement of placental hormones on bone mineralization (Trotter and Pohlandt, 
2000) and antenatal progesterone therapy on postnatal lung function (Dodd et al., 2009). 
However, assessments of neurodevelopmental outcomes was limited and while showing no 
adverse effects, examination of neurodevelopmental parameters was not an objective of 
these studies.  
4.3.1.2. Longer-term progesterone treatment 
Without the continued supply of placentally derived steroids or exogenous 
supplementation, concentrations of progesterone will decline in the neonatal period, thus 
resulting in a prolonged deficit of neuroactive steroid concentrations. We have recently 
examined longer progesterone treatment in guinea pigs. The guinea pigs were again 
delivered at 62 days of gestation and in these studies were treated with progesterone for 8 
days until term equivalence.  The key finding of this work was that administration of 
progesterone enhanced the endogenous synthesis of allopregnanolone, with levels in 
preterm brain remaining elevated until the equivalent of term delivery. Progesterone 
concentrations achieved in the plasma differed between males and females indicating there 
may be sex-specific changes in plasma steroid metabolism even in these prepubertal 
animals. In contrast, allopregnanolone concentrations in the brain were similar between 
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male and female neonates at 8 days of age (Kelleher, 2013). This observation however, does 
not discount the possibility of differences in other neuroactive progesterone metabolites. 
Overall this work supports the conclusion that there is capacity for the infant brain to 
synthesis allopregnanolone from progesterone. This work is also consistent with previous 
studies of neuroactive steroids in fetal sheep following adrenalectomy and hypophysectomy 
that showed independent regulation of synthesis and steroidogenic enzyme expression in 
the fetal brain (Nguyen et al., 2004a).  
 
We have also investigated the longer term offspring outcomes following 8 days of 
progesterone supplementation to preterm neonates. Despite the elevated allopregnanolone 
levels in the brain we did not observe any overt sedative effects (van Broekhoven et al., 
2007) or any changes in overall activity in the progesterone treated guinea pigs 
(unpublished observations). In preliminary studies, we further examined behaviour in the 
novel object recognition trials at 21 days of age. We found that while both the 
progesterone- and vehicle-treated animals demonstrated a similar preference in exploration 
time of the novel object, the progesterone treated animals spent more time exploring (Fig. 
11). This finding suggests altered behaviour with potentially reduced anxiety in the 
progesterone treated group. The effects of neuroactive steroid may differ greatly with the 
timing of administration and the age at behavioural testing. The effect of administering 
neuroactive steroid on activity has been found to vary markedly with age in adult rats 
(Darbra et al., 2012).  Thus, our recent studies have shown that changes in neuroactive 
steroid levels induced by progesterone in the preterm guinea pig brain can modify 
behaviour in young guinea pigs. This information has important implications for the use of 
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steroid therapies in the perinatal period, particularly with progesterone in preterm infants. 
Such treatment may influence long-term neurobehavioural outcomes.   
In conclusion, our studies show preterm delivery in the guinea pig resulted in reduced 
myelination and a premature reduction in allopregnanolone levels in the neonatal brain. 
Progesterone and its neuroactive steroid metabolites may have important effects on 
postnatal processes of myelination, a key developmental pathway adversely affected by 
preterm birth.  
 
4.5. Adverse effects of stress exposure during pregnancy on the offspring 
 
The perinatal period is a time of enhanced neural plasticity, and as such the development of 
the brain is subject to remodelling. Adverse events in early life such as exposure to stress 
during pregnancy can adversely ‘programme’ physiological systems and behaviours in later 
life (Meaney et al., 2007).  
 
In the following sections we will discuss the adverse effects of exposure to stress or 
excessive glucocorticoids during pregnancy on the offspring. We will first consider the fetus 
before discussing the longer term consequences for the offspring. In both cases there will be 
an emphasis on how stress or excessive glucocorticoid exposure may impact upon 
neurosteroid generation and its normal protective roles.   
 
4.5.1. Effects of stress/excessive glucocorticoid exposure during pregnancy on the fetus  
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Studies in pregnant guinea pigs have shown that repeated administration of the synthetic 
glucocorticoid, betamethasone, reduces 5α-reductase-2 expression in the placenta 
(McKendry et al., 2010).  Interestingly, enzyme expression and allopregnanolone levels in 
the brain are also suppressed by betamethasone treatment, but this is only observed in 
male fetuses. Importantly, repeated exposure to betamethasone is required to induce these 
changes; a single course of betamethasone does not affect either 5α-reductase-2 or 
allopregnanolone levels (Hirst et al; unpublished observations). This is consistent with 
clinical outcomes reported in long-term follow-up of pregnancies where a single course of 
betamethasone was administered (Dessens et al., 2000). Therefore, with regard to 
allopregnanolone production, these studies indicate there are no adverse effects of short-
term exposure to betamethasone and thus acute exposure in pregnancy may not be 
detrimental.   
 
There remains controversy over repeated exposure to synthetic glucocorticoids, with animal 
studies showing adverse effects on brain development (Newnham and Jobe, 2009). Our 
studies indicate these effects may be mediated by changes in allopregnanolone levels in the 
brain. We have shown that suppression of neuroactive steroid synthesis using the 5α-
reductase inhibitor, finasteride, reduces cell number and disrupts normal apoptotic 
processes in the brain of fetal sheep (Yawno et al., 2009).  The premature decline in 
allopregnanolone and of other neuroactive steroid levels following preterm labour in guinea 
pigs is also associated with reduced myelination (Kelleher et al., 2011). In preliminary 
studies we have observed that the premature loss of neuroactive steroids after preterm 
birth caused changes in performance in open field tests which can be restored by 
progesterone replacement (Fig. 11). This suggests that the adverse effects of loss of 
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neuroactive steroid in the fetal brain translate into behavioural changes in later life (also see 
Section 4.5.4.).   
 
We have investigated the effect of stress during pregnancy on neuroactive steroid 
production pathways and on behavioural changes in the offspring of pregnant guinea pigs. 
These studies were designed to determine if the suppressive effects of repeatedly elevated 
glucocorticoid exposure on neuroactive steroid production translates into adverse neonatal 
outcome. In contrast to synthetic steroids, such as betamethasone, the fetus is normally 
protected from the higher concentrations of endogenous glucocorticoids, i.e. cortisol, in 
maternal plasma by a placental barrier that is formed from the expression of 11β-
hydroxysteroid dehydrogenase type-2 (11β-HSD2) (Benediktsson et al., 1997). This enzyme 
converts cortisol into the markedly less potent metabolite, cortisone, such that only a small 
proportion of maternal cortisol reaches the fetal circulation (Seckl and Holmes, 2007). 
However, during episodes of stress maternal cortisol concentrations increase markedly and 
may exceed metabolic capacity, allowing a greater proportion of maternal cortisol to cross 
the placenta and so enter the fetal circulation. Furthermore, prolonged exposure to 
episodes of stress may reduce the expression and activity of the enzymatic barrier (Welberg 
et al., 2005; Williams et al., 1999).  
 
Animal studies suggest greater sensitivity to prenatal stress at key periods in late gestation; 
however, consideration of the species is important in the translation of findings to human 
pregnancy. We have use an established model of prenatal stress in guinea pigs developed by 
Kapoor and co-workers (Kapoor and Matthews, 2005) to examine the effect of prenatal 
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maternal stress on neuroactive steroid synthesis pathways. Previous studies by these 
investigators, using this model, have shown that maternal anxiety that causes activation of 
the maternal HPA axis leads to markedly altered stress responses in the offspring (Kapoor 
and Matthews, 2008; Matthews and Phillips, 2010). The maternal stress leads to increased 
responsiveness of the HPA axis in the newborn, and these changes in responsiveness 
continue into adult life (Matthews and Phillips, 2010).  There are distinct sex differences in 
effects on the HPA axis, with the most marked effects observed in the male offspring 
(Matthews and Phillips, 2010). Guinea pigs deliver more mature offspring compared to 
laboratory rats, thus guinea pigs have a greater amount of brain development sensitive to 
maternal stress.  In recent preliminary studies we have found maternal injection of 
allopregnanolone caused an expected increase in allopregnanolone concentrations in both 
control and prenatally stressed exposed dams.  Interestingly, while allopregnanolone 
concentrations also increased in the fetal circulation of control pregnancies, no increase was 
observed in fetuses where the mother had been exposed to stress during gestation (Bennett 
GA, 2013). This suggests mechanisms involved in neuroactive steroid transfer to the fetus 
may be altered or that metabolic pathways may be stimulated by prenatal stress.  Further 
studies are needed to determine if only allopregnanolone is affected or if there is an overall 
stress-induced disruption of neuroactive steroid pathways or placental transfer capacities.  
In addition to influencing responses to allopregnanolone treatment, the offspring from 
prenatally stressed pregnancies displayed greater anxiety in open field tests (Bennett GA, 
2013). Together these data suggest profound effects of prenatal stress on offspring 
behaviour that may involve disruption of neuroactive steroid pathways.  
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4.5.2. Effects of stress exposure during pregnancy on the offspring in later life  
 
Fetal programming as a result of stress exposure during pregnancy can increase the 
susceptibility of the offspring to disease in later life, such as cardiovascular disease, diabetes 
mellitus type 2, metabolic syndrome and affective disorders. The majority of studies 
investigating the effects of prenatal stress exposure in the offspring have been performed in 
rodents. In these models prenatal stress has been associated with offspring of low birth 
weight (Brunton and Russell, 2010b; Brunton et al., 2013), an anxious-behaviour phenotype 
(Brunton and Russell, 2010b; Fan et al., 2009; Vallee et al., 1997), enhanced HPA axis activity 
under basal conditions (Koehl et al., 1997; Koehl et al., 1999)and in response to stress 
(Brunton and Russell, 2010b; Fan et al., 2009; Koenig et al., 2005; McCormick et al., 1995; 
Takahashi and Kalin, 1991; Weinstock et al., 1992), impaired immune function, disrupted 
glucose homeostasis (Brunton et al., 2013), insulin resistance (Nilsson et al., 2001), 
hypertension (Igosheva et al., 2004), obesity (Nilsson et al., 2001; Tamashiro et al., 2009), 
altered nociception (Butkevich et al., 2006; Sternberg and Ridgway, 2003), cognitive deficits 
(Lemaire et al., 2000; Yaka et al., 2007) and atypical social and reproductive behaviours 
(Frye and Orecki, 2002a, b; Holson et al., 1995; Lee et al., 2007). 
4.5.3. Mechanisms of altered HPA axis regulation in prenatally stressed offspring  
 
As mentioned above, the HPA axis is particularly sensitive to fetal programming by stress or 
exposure to excessive levels of glucocorticoids during pregnancy. It has been proposed that 
disrupted HPA axis regulation may underlie many of the negative phenotypes (described in 
Section 4.5.) observed in the offspring of mothers exposed to stress during gestation (Levitt 
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et al., 2000; Phillips et al., 2000; Phillips et al., 1998; Reynolds et al., 2001), so it is 
appropriate to focus on what is known about the mechanisms involved in HPA axis 
dysregulation in prenatally stressed offspring.  
4.5.3.1. Increased forward drive and impaired negative feedback control 
Generally prenatally stressed (PNS) offspring display enhanced HPA axis responses to stress 
in adulthood (Bosch et al., 2007; Brunton and Russell, 2010b; Fride et al., 1986; McCormick 
et al., 1995; Peters, 1982; Takahashi and Kalin, 1991; Weinstock et al., 1992) (Fig. 12). 
Greater ACTH and hence corticosterone secretory responses to acute stress in adulthood in 
PNS offspring results from increased drive by the hypothalamic CRH and/or vasopressin 
neurones (Brunton and Russell, 2010b) and is indicated by greater levels of POMC mRNA in 
the anterior pituitary and greater levels of CRH mRNA and vasopressin mRNA in the pPVN of 
PNS rats compared with the controls (Brunton and Russell, 2010b).  
 
HPA axis responses to stress are often prolonged in comparison with controls (Barbazanges 
et al., 1996; Brunton and Russell, 2010b; Henry et al., 1994; Morley-Fletcher et al., 2003), 
indicative of impaired glucocorticoid negative feedback control of the HPA axis. This is 
probably a consequence of reduced hippocampal glucocorticoid and/or mineralocorticoid 
binding sites; indeed gestational stress is associated with reduced hippocampal expression 
of GR (Szuran et al., 2000; Weinstock et al., 1992), MR (Barbazanges et al., 1996; Brunton 
and Russell, 2010b; Maccari et al., 1995) or both receptors (Henry et al., 1994) in the 
offspring, depending upon the prenatal stress paradigm used and/or gender of the 
offspring. The mechanisms involved in down-regulation of hippocampal GR and/or MR 
expression in prenatally stressed rats are not fully understood, though these probably 
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involve epigenetic changes. GR and MR mRNA are detected in the fetal hippocampus from 
days 13 and 16 of pregnancy, respectively (Diaz et al., 1998), thus exposure to excessive 
levels of maternal glucocorticoids in utero may be able to influence GR and/or MR 
expression via direct interactions with the GR and/or MR gene promoters. Indeed, 
decreased GR mRNA expression in the hippocampus of adult male offspring of mice exposed 
to maternal chronic variable stress in early pregnancy is associated with increased 
methylation in the exonic region of the GR gene (Mueller and Bale, 2008) and elevated 
ACTH and corticosterone secretory responses to acute stress compared with controls. 
Furthermore, differential HPA axis responses in offspring exposed to varying quality of 
postnatal maternal care have also been attributed to histone acetylation and the 
methylation state of the GR gene in the hippocampus (Szyf et al., 2005).   
 
4.5.4. Effects of prenatal stress on anxiety behaviour 
 
PNS rats generally exhibit a greater degree of anxiety-related behaviour in adulthood (Vallee 
et al., 1997). PNS rodents display reduced locomotion and exploration in the open field 
(Poltyrev et al., 1996; Wakshlak and Weinstock, 1990), spend less time on the open arms of 
the elevated plus maze (Brunton and Russell, 2010b; Poltyrev et al., 1996; Vallee et al., 
1997; Wang et al., 2013) and display increased startle responses (Tazumi et al., 2005; Vallee 
et al., 1997). Increased anxiogenic behaviour in PNS offspring has been related to a 
reduction in the central expression of benzodiazepine receptors in the central amygdala and 
hippocampus (Barros et al., 2006), which may indicate reduced GABA-stimulated chloride 
ion influx and deficient inhibitory regulation of neurones in these regions by GABA.  
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Studies of human pregnancy have provided evidence of the negative impact of maternal 
anxiety/emotional stress on fetal neurodevelopment and behavioural outcomes. Increasing 
evidence shows that maternal prenatal psychosocial stressors, experienced in many 
pregnancies, exert negative effects on the fetus. These studies have shown that maternal 
state anxiety is associated with hyperactivity and attention deficits at 5 years of age 
(Loomans et al., 2011).  Interestingly, relatively short episodes of acute anxiety appear 
sufficient to cause ongoing effects, with some of the best evidence coming from natural 
disasters. For example, high levels of stress experienced in pregnancies following the 
Quebec ice storm showed negative effects on intellectual capacity in the offspring from 
these pregnancies (Laplante et al., 2008).  
 
4.5.4.1. Central CRH system and increased anxiety in prenatally stressed offspring 
Central administration of CRH is anxiogenic and central administration of a CRH antagonist 
can block fear responses in PNS rats (Ward et al., 2000), hence increased anxiety-like 
behaviour in PNS rats may be mediated via enhanced central CRH release or action (Britton 
et al., 1982; Britton et al., 1986; Dunn and Berridge, 1990; Dunn and File, 1987).  
 
The central nucleus of the amygdala (CeA) mediates anxious behavioural responses and CRH 
expressing neurones in the CeA are considered to be importantly involved in mediating 
anxious behavioural responses (Schulkin et al., 1998).  The offspring of dams exposed to 
stress during gestation display increased CRH mRNA expression (Brunton and Russell, 
2010b), CRH content and release (Schulkin et al., 1998) in the CeA. This may be explained by 
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epigenetic modifications, as in prenatally stressed male mice increased anxiety-like 
behaviour and increased CRH mRNA expression in the amygdala is associated with hypo-
methylation in the promoter region of the CRH gene (Mueller and Bale, 2008).   
 
Glucocorticoids and stress up-regulate CRH mRNA expression in the amygdala (Hsu et al., 
1998; Makino et al., 1994) and central corticosteroid receptors facilitate anxiety-type 
behaviours (Calvo and Volosin, 2001). Consistent with this are the findings of greater GR 
binding and GR mRNA expression in the amygdala of male PNS offspring (Brunton and 
Russell, 2010b; McCormick et al., 1995), indicating increased GR expression may facilitate 
up-regulation of CRH and hence anxiety behaviour in PNS offspring. 
  
Lastly, altered CRH receptor expression may also be involved in increased anxiety 
behaviours induced by prenatal stress exposure. There are two types of CRH receptors 
expressed in the brain. The CRH type 1 receptor (CRH-R1) mediates stimulation of 
neuroendocrine stress responses and anxious behaviours, while the type 2 receptor (CRH-
R2) may be important, as a mediator of urocortin 2/3 actions, for dampening stress 
responses and anxiety (Bale et al., 2000). Expression of CRH-R1 (pro-anxiogenic) mRNA is 
increased (Brunton and Russell, 2010b), while expression of CRH-R2 (pro-anxiolytic) mRNA is 
decreased in the amygdala in PNS male offspring (Brunton et al., 2011; Zohar and 
Weinstock, 2011), which may contribute to increased anxiogenic actions of CRH, and 
decreased possible anxiolytic actions of urocortins 2/3, and thus explain the anxious 
phenotype in PNS rats. Moreover, adult male offspring of mothers exposed to hypoxia 
throughout gestation also display increased anxiety-like behaviour, concomitant with 
increased CRH-R1 mRNA expression in the PVN. This occurs as a result of demethylation at 
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several CpG islands in the CRH-R1 promoter and can be detected in the late gestational 
fetus and persists into adulthood (Wang et al., 2013). 
  
4.5.5. A role for altered neurosteroidogenesis in prenatally stressed offspring 
In addition to the reduced capacity of the fetal brain to synthesise allopregnanolone in 
response to IUGR described above (see Section 4.2.), neurosteroidogenesis may also be 
compromised post-natally in the brain of PNS rat offspring.  
Allopregnanolone levels in the brains of female juvenile offspring born to mothers exposed 
to an immune stressor in late pregnancy are reduced, as is progesterone utilisation (the 
ratio of 5α-reduced metabolites to progesterone) in the hippocampus (Paris et al., 2011b). 
Reduced conversion of progesterone to its 5α-reduced metabolites has also been reported 
in the prefrontal cortex of male and female juvenile offspring born to mothers exposed to 
repeated restraint during pregnancy, and this is associated with impaired cognitive 
performance (Paris and Frye, 2011).  
 
The effects of stress exposure during pregnancy on neurosteroidogenesis in the offspring 
evidently persist into adulthood. Allopregnanolone levels are markedly reduced in 
hypothalamic, midbrain and whole brain homogenates from adult male prenatally stressed 
rats (Brunton, Russell et al; unpubl.). Intriguingly, the level of stress experienced by the dam 
during her pregnancy is inversely proportional to central allopregnanolone concentrations in 
her male PNS offspring (Brunton, Russell et al; unpubl.). Furthermore, adult male prenatally 
stressed offspring have reduced levels of the 5α-reduced metabolite of testosterone, 
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dihydrotestosterone, in their hippocampus (Walf and Frye, 2012). Taken together, the data 
from studies in PNS juveniles and adults point to decreased neurosteroidogenesis as a result 
of reduced 5α-reductase activity. Indeed, we have recently found that prenatal stress is 
associated with reduced expression of 5αR mRNA in brain regions that provide excitatory 
drive to the HPA axis, such as the PVN and NTS (Brunton, Russell et al; unpubl.). In addition 
we have recently reported reduced gene expression for 5α-reductase in the liver of adult 
PNS offspring (Brunton et al., 2013), thus reduced metabolism of progesterone into 
allopregnanolone in the periphery could potentially also contribute to reduced 
allopregnanolone levels in the brain.  
 
The mechanisms of reduced neurosteroidogenesis in prenatally stressed offspring are not 
understood, however insufficient allopregnanolone production in the stressed dam may be  
a factor, as reduced circulating allopregnanolone concentrations in stressed mothers predict 
reduced formation of allopregnanolone in the prefrontal cortex of her offspring in later life 
(Paris and Frye, 2011). 
4.5.6. Allopregnanolone and reversal of fetal programming effects 
 
Given that allopregnanolone has been shown to have anxiolytic actions and is able to reduce 
HPA axis responses to stress (Frye and Rhodes, 2006; Patchev et al., 1996; Patchev et al., 
1994), it would seem a likely candidate for normalising the anxious-type phenotype and 
hyperactive HPA axis responses to stress observed in adult animals prenatally programmed 
by maternal stress exposure. Our recent unpublished findings indicate that short-term 
allopregnanolone treatment, given peripherally, can indeed normalise ACTH responses to an 
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acute stress challenge in adult PNS rats. Moreover, targeted up-regulation of 5α-reductase 
and 3αHSD expression in the brain in PNS rats can reverse the hyperactive HPA axis 
responses to stress (Brunton, Russell et al., unpubl.). Hence, 5-reduced steroids can 
evidently over-write fetal programming, at least in terms of hyperactive HPA axis responses 
to stress. Moreover, simultaneous administration of allopregnanolone to pregnant dams 
exposed to gestational stress ameliorates some of the negative affective behaviours in the 
offspring associated with prenatal stress exposure. At one week of age, PNS pups whose 
mothers were treated with allopregnanolone (at the same time as the stress exposure) 
emitted fewer ultrasonic vocalizations in response to brief maternal  separation, and 
displayed reduced anxiety-like behaviour on the elevated plus maze as adults (10 weeks of 
age) compared with offspring of stressed mothers administered vehicle (Zimmerberg and 
Blaskey, 1998). Whether post-natal allopregnanolone treatment exerts similar effects on 
anxiety-like behaviour in PNS rats is not yet known.  
 
Allopregnanolone has been shown to have neuroprotective effects. It can reduce cell death 
and cognitive impairments induced by traumatic brain injury or cerebral ischaemia (Djebaili 
et al., 2004) (Morali et al., 2011) and reverse cognitive deficits in a mouse model of 
Alzheimer's disease (Wang et al., 2010). Whether allopregnanolone also reverses the effects 
of prenatal stress exposure on other programmed phenotypes, e.g. impaired cognition is 
not clear, but warrants further investigation.  
 
The mechanisms through which allopregnanolone normalises HPA axis responses to stress 
and indeed anxiety behaviour remain to be elucidated. Given the potent actions of 
allopregnanolone exerted via GABAA receptors in mediating inhibition of the HPA axis 
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(Cullinan et al., 2008), this seems a distinct possibility. Another possibility is that 
allopregnanolone normalises HPA axis responses to stress in PNS rats through a mechanism 
similar to that which explains attenuated stress responses in late pregnancy, i.e. an 
allopregnanolone dependent up-regulation of endogenous opioid inhibition (see Section 
2.2.2.). Indeed central opioid and opioid receptor expression is reduced in PNS rats (Insel et 
al., 1990; Sanchez et al., 1996; Weinstock et al., 1992). 
 
5. CONCLUSIONS AND FUTURE PERSPECTIVES 
 
It is well-known that in mammals progesterone, secreted by the ovulated ovarian follicle(s), 
has an essential role in preparing the uterus for implantation and to maintain uterine 
quiescence so the pregnancy can continue. Subsequently, with estrogen, progesterone acts 
in the mother's brain to ensure that maternal behaviour is expressed when the young are 
born. These essential actions of progesterone are via progesterone receptors. Here we have 
given accounts of actions of allopregnanolone, a neurosteroid metabolite of progesterone 
that is formed by the action of specific enzymes in various tissues, including the brain, 
where it is present in high concentrations especially in late pregnancy. Allopregnanolone has 
actions in the brains of the mother and the fetuses that can be viewed as optimising the 
quality of the outcome of pregnancy, for the mother and offspring. Allopregnanolone does 
not act via steroid receptors; instead it acts on GABAA receptors on neurones that mediate 
the actions of GABA, the major inhibitory neurotransmitter in the brain, and thereby 
increases the effectiveness of GABA.  
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We have reviewed evidence which shows that allopregnanolone has important roles during 
pregnancy in quelling the responsiveness of the body's major neuroendocrine stress 
response system, the HPA axis.  This action of allopregnanolone saves energy and gives the 
fetuses some protection from adverse programming by actions of glucocorticoid. 
Allopregnanolone also restrains responses of neurones that make and secrete oxytocin to 
stimulate uterine contractions during birth; this action of allopregnanolone is considered to 
help prevent preterm births. The actions of allopregnanolone on oxytocin neurones are 
partly direct, on GABAA receptors, and partly indirect through induction of an opioid peptide 
inhibitory mechanism in the brainstem, in the noradrenergic pathway that conveys neural 
signals from the uterus. This pathway also conveys information about physical stressors, and 
the same opioid mechanism induced by allopregnanolone that quietens the oxytocin system 
is responsible for reduced HPA axis stress responses in pregnancy. 
 
The fetal brain is also exposed to, and produces allopregnanolone, and this is important in 
reducing the impact of hypoxia, which may be experienced during a difficult birth, and result 
in excitotoxic brain damage. This is more likely in fetuses that have experienced intra-
uterine growth retardation, which decreases allopregnanolone production in the brain, 
resulting in impaired myelination. Preterm birth has similar consequences, and the reduced 
allopregnanolone production in the brain continues after birth, with impaired myelination 
and neurobehavioural outcomes. Despite the protection afforded by reduced HPA axis 
responses in late pregnancy (due to allopregnanolone), exposure of pregnant animals to 
stress can adversely programme the offspring to be more anxious and more responsive to 
stress. This phenotype involves reduced allopregnanolone production in the brains of the 
adult offspring. The possibility of over-riding the abnormal neurodevelopmental phenotypes 
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caused by such adverse prenatal events by giving allopregnanolone or progesterone 
supplements before or after birth were also discussed. The prospect that the adverse effects 
in the offspring of compromised pregnancies may be reversed by manipulations such as 
these is an exciting area warranting further research and may have important implications 
for humans. 
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FIGURE LEGENDS 
Figure 1: The GABAA receptor 
GABAA receptors are ligand-activated chloride channels comprised of five transmembrane 
subunits which form the chloride ion channel. The most common receptor stoichiometry is 
two α subunits, two β subunits and either a γ (top left) or δ subunit (bottom left). The 
functional properties of the GABAA receptor depend upon subunit composition and subunit 
arrangement. The GABA binding sites at the α1 and β2 interfaces are indicated. When 
activated by GABA, the chloride ion (Cl-) channel opens, permitting chloride ion influx (right) 
and thus hyperpolarisation of the post-synaptic cell membrane. Allopregnanolone binds to a 
site in the transmembrane regions of the α and β subunits that is distinct from the GABA 
site, and acts to prolong opening time of the channel (Belelli and Lambert, 2005; Hosie et 
al., 2006; Sigel and Steinmann, 2012). 
 
Figure 2: Estradiol and progesterone profiles during pregnancy in the rat and sheep 
Concentrations of progesterone (solid line) and 17β-estradiol (dotted line) in: a) the 
maternal circulation of the rat, and b) the maternal circulation of the sheep. In each case 
hormone concentrations are expressed as a percentage of the maximum levels found in 
pregnancy, owing to variations in actual levels across different studies. Data are derived as 
follows: rat progesterone and estradiol (Mann and Bridges, 2001); sheep progesterone (Lea 
et al., 2007); sheep estradiol (Challis, 1971). Data in a) are reproduced from (Brunton and 
Russell, 2010a) with permission from Elsevier (licence number: 3154511277783). 
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Figure 3: Peripheral and central allopregnanolone concentrations in the rat during 
pregnancy  
Concentrations of allopregnanolone in: a) maternal plasma, and b) the maternal brain 
(cerebral cortex). In each case hormone concentrations are expressed as a percentage of 
the maximum levels found in pregnancy. Data are derived from (Concas et al., 1998). Data in 
a) are reproduced from (Brunton and Russell, 2010a) with permission from Elsevier (licence 
number: 3154511277783). 
 
Figure 4: Contribution of enzyme pathways in the sheep placenta and fetal brain to 
allopregnanolone concentrations 
5-R1, R2, 5-reductase-1 or -2; 3β-HSD, 3β-hydroxysteroid dehydrogenase; 5-DHP, 5-
dihydroprogesterone; 3-HSD, 3-hydroxysteroid dehydrogenase; P450scc, cholesterol 
side-chain cleavage enzyme that catalyses the conversion of cholesterol to pregnenolone. 
Based on studies in sheep (Nguyen et al., 2003). Allopregnanlone is produced in the 
maternal brain in pregnancy, as in the fetal brain, but via 5-R1, not 5α-R2. 
 
Figure 5: Allopregnanolone-opioid mechanisms involved in suppressed HPA axis responses 
in late pregnant rats 
Brain and circulating levels of progesterone are increased (↑) in pregnancy. Progesterone is 
converted into allopregnanolone (AP) by the sequential actions of 5-reductase (5R), and 
3-hydroxysteroid dehydrogenase (3HSD) [see Fig 4]. Increased 5αR activity in late 
pregnancy leads to increased AP production for local action. In brainstem nucleus tractus 
solitarii (NTS) neurones, AP increases levels of proenkephalin-A (pENK-A) mRNA, which is 
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translated into enkephalins (opioid peptides). Noradrenergic A2 neurones project to 
parvocellular corticotrophin-releasing hormone (CRH) neurones in the paraventricular 
nucleus (PVN). Noradrenaline (NA) released in the PVN excites the CRH neurones via 1 
adrenoreceptors. In pregnancy, interleukin-1β (IL-1) fails to evoke noradrenaline release 
from NTS neurone terminals in the PVN. This is a result of increased opioid inhibition (by 
enkephalin) acting presynaptically on the up-regulated -opioid receptors (MOR), 
presumptively on the noradrenergic nerve terminals. Based on data from (Brunton et al., 
2009; Brunton et al., 2005). In addition, AP may inhibit CRH neurones by modulating GABA 
inputs to the PVN by its actions on GABAA receptors. AP acts allosterically on GABAA 
receptors to prolong the opening time of chloride (Cl-) ion channels, enhancing inhibitory 
GABA neurotransmission (Gunn, 2010). Thus in pregnancy, AP prevents activation of the 
CRH neurones, thereby inhibiting CRH release at the median eminence (ME) and preventing 
HPA axis responses to IL-1. 
 
Figure 6: Oxytocin neurone afferents and projections 
Magnocellular oxytocin (OT) neurones located in the supraoptic nucleus (SON) and the 
paraventricular nucleus (PVN) send axons to the posterior lobe of the pituitary gland. 
Oxytocin is secreted from nerve terminals into the circulation to act at distant organs e.g. 
uterus, mammary glands, heart. Magnocellular oxytocin neurones receive afferent inputs 
from arcuate nucleus, lamina terminalis and the nucleus tractus solitarii (NTS). Oxytocin is 
also released from dendrites in the SON and PVN where it can act locally on the oxytocin 
neurones themselves, or diffuse to influence other hypothalamic and possibly extra-
hypothalamic neurones. Parvocellular oxytocin neurones in the PVN project to limbic brain 
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regions and release oxytocin from their axon terminals. A2: noradrenergic neurones; CeA: 
central nucleus of amygdala; MPOA: medial preoptic area; POMC: pro-opioimelanocortin. 
 
Figure 7: Oxytocin neurone activation at parturition: The Ferguson Reflex 
Co-ordinated burst firing of magnocellular oxytocin neurones triggers pulsatile oxytocin (OT) 
secretion into the blood from the nerve terminals in the posterior pituitary. OT acting on up-
regulated OT receptors (OTR) in the uterus stimulates (+) uterine contractions and increases 
intrauterine pressure (I.U.P.), resulting in pup expulsion. The stretching of the birth canal 
activates (+) neural pathways to noradrenergic neurones in the A2 region of the nucleus 
tractus solitarii (NTS). Activation of these noradrenaline (NA) producing neurones in the NTS 
can be mimicked experimentally with intravenous infusion of OT pulses in d22 pregnant rats 
which causes induction of Fos (an immediate early gene indicative of recent activation) 
immunoreactivity (ir) in the cell bodies of the NTS neurones. The noradrenergic neurones 
project to oxytocin neurones in the supraoptic (SON) and paraventricular (PVN) nuclei, 
where they release noradrenaline which directly excites (+) the OT neurones. 
Experimentally, in late pregnant rats intravenous OT pulses stimulate (+) NA release in the 
SON (Douglas et al., 2001)This pathway is a classic positive feedback loop, referred to as the 
‘Ferguson reflex’. Asterisks in red circles (numbered 1-4) indicate sites of direct or indirect 
progesterone actions in pregnancy to prevent premature activation of the Ferguson reflex 
(Antonijevic et al., 2000; Brunton et al., 2012), and hence premature birth: 1*: direct 
progesterone action, via progesterone receptors; 2* indirect induction of pro-enkephalin-A 
mRNA expression action via locally produced allopregnanolone; *3: inhibitory action of up-
regulated (allopregnanolone-induced) opioid peptide from NTS; *4: direct inhibitory action 
of allopregnanolone via GABAA receptors.     
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Figure 8: Micro-environment of magnocellular oxytocin neurones 
Schematic detailing the different micro-environments of magnocellular oxytocin neurones 
a) without pregnancy, b) during late pregnancy (ca. 48 h before expected births), and c) at 
term.  a) Without pregnancy, the dendrites and cell bodies of magnocellular oxytocin (OT) 
neurones in the supraoptic (SON) and paraventricular (PVN) nucleus receive excitatory 
glutamate (GLU) and noradrenaline inputs and inhibitory GABA inputs. Oxytocin released 
from the dendrites auto-stimulates endocannabinoid (eCB) production. In turn, eCBs inhibit 
glutamatergic inputs to the oxytocin neurones. Oxytocin neurones also produce nitric oxide 
(NO) when activated and NO inhibits oxytocin neurones directly and by acting 
presynaptically on GABAergic inputs.  
b) In late pregnancy, increased levels of progesterone (P) lead to increased 
allopregnanolone (AP) formation: in the periphery and in brain by glia and neurones. AP 
potentiates inhibitory actions of GABA via actions on GABAA receptors. The noradrenergic 
input is restrained by an endogenous opioid possibly met-enkephalin from proenkephalin-A, 
pENK-A, up-regulated in nucleus tractus solitarii neurones by AP actions. Inhibition of 
oxytocin neurones by other endogenous opioid peptides (eOP; possibly β-endorphin from 
the arcuate nucleus) may also be increased; oxytocin neurones can produce more NO. At 
the posterior pituitary, a κ-opioid mechanism restraining oxytocin secretion in early 
pregnancy is now down-regulated. 
c) At the end of pregnancy progesterone and hence AP levels fall dramatically and 
potentiation by AP of GABA inhibition of oxytocin neurones is lost; the inhibitory activity of 
the NO system is down-regulated: oxytocin neurones are now more responsive to excitatory 
inputs. eOP restraint on noradrenergic input oxytocin neurones is also reduced at this time. 
Together these adaptations permit greater stimulation of oxytocin secretion by arriving 
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actions potentials, in the Ferguson reflex central arc. Synchronised or ‘burst’ firing of 
oxytocin neurones in parturition, driven by oxytocin released by dendrites, with direct 
opioid inhibition lifted, causes secretion of pulses of oxytocin into the blood, which acts to 
stimulate uterine contractions and births. The stretching of the birth canal provides positive 
feedback to the noradrenergic inputs to oxytocin neurones to further drive oxytocin 
secretion. Based on data from (Brunton et al., 2012; Brunton et al., 2005; Douglas et al., 
1993b; Douglas et al., 1995; Jo et al., 2011; Oliet et al., 2007; Srisawat et al., 2000; Stern and 
Ludwig, 2001; Tobin et al., 2010).  
 
Figure 9: Effect of progesterone treatment on plasma allopregnanolone concentrations in 
neonatal guinea pigs 
Plasma concentrations of allopregnanolone in fetuses (n=9, black bars), term neonates 
(n=12, grey bars), 24 hour old preterm neonates (n=9, open bars) and preterm progesterone 
treated neonates (n=9, hashed bars). Each bar represents mean ± SEM. Asterisks indicate 
significant differences between groups (*p<0.05, **p<0.01, *** p<0.001). Based on data 
from (Kelleher, 2013). 
 
Figure 10: 5α-reductase-2 in the fetal brain of term and preterm neonatal guinea pigs 
Relative expression and representative western blots for 5α-reductase type 2 in the brains 
of fetuses (n=16, black bars), term neonates (n=11, grey bars), preterm neonates (n=12, 
open bars) and preterm progesterone treated neonates (n=8, hashed bars). Bars represent 
mean ± SEM. Asterisks indicate significant differences between groups (*p<0.05). Based on 
data from (Kelleher, 2013). 
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Figure 11: Anxiety behaviour in premature guinea pigs 
Behavioural improvement in neonatal guinea pigs born 8 days prematurely (62 days of 
gestation).  Entries into the inner zone of the open field were measured with animals at 8 
days of age (term equivalent). Control; vehicle treatment for 8 days commencing after birth 
and progesterone (16mg/kg/day) treatment.  Increased visits to the inner zone of the open 
field indicates reduced anxiety. Cont n=13, Prog n=10, P<0.05. Data from Kelleher MA, 
Palliser HK, Hirst JJ (2011) Progesterone replacement therapy & brain development in the 
preterm neonate. Australian Society for Medical Research 19: Abs O3.5. 
 
Figure 12: The dynamic range of ACTH responses to stress in adult female rats depending 
on allopregnanolone availability and life experience. 
Peak plasma ACTH responses 15 min post-interleukin-1β (IL-1β) administration in female 
rats. Data are expressed as a percentage of the response measured in virgin controls. The 
ACTH response is significantly reduced in day 21 pregnant (preg) rats, and partially restored 
by inhibiting allopregnanolone (AP) production by short-term treatment with the 5α-
reductase inhibitor, finasteride (FIN). Conversely, administration of AP suppresses the ACTH 
response to IL-1β in virgin rats. The ACTH response to IL-1β in adult female offspring 
exposed to prenatal social stress (PNS) is approximately 3-fold greater than in female 
controls and this can be normalised by prior AP treatment. The dashed line indicates the 11-
fold dynamic range in the ACTH response to IL-1β in female rats that is evidently governed 
by availability of AP. Based on data from (Brunton et al., 2009; Brunton and Russell, 2010b). 
Data are reproduced from (Brunton and Russell, 2011) with permission from Elsevier 
(licence number: 3154511510262). 
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